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STUDIES	  IN	  THE	  IMMUNE	  CONTROL	  OF	  HERPES	  SIMPLEX	  VIRUS	  TYPE	  1	  (HSV-­‐1)	  
LATENCY:	  THE	  ROLE	  OF	  CD4+	  T	  CELLS	  AND	  IL-­‐10	  IN	  HSV-­‐1	  LATENCY	  Brooke	  L.	  Sullivan,	  M.S.	  	  University	  of	  Pittsburgh,	  2015	  	  	  Herpes	  simplex	  virus	  1	  (HSV-­‐1)	  infection	  of	  the	  eye	  results	  in	  lytic	  viral	  replication	  in	  the	  corneal	   epithelium	   followed	   by	   a	   quiescent	   infection	   of	   the	   sensory	   neurons	   of	   the	  trigeminal	   ganglia	   (TG),	  which	   innervate	   the	   cornea.	  Reactivation	  of	   the	  HSV-­‐1	   from	   this	  latent	   state	   can	   result	   in	   pathologies,	   such	   as	   stromal	   keratitis	   in	   the	   eye	   and	   viral	  encephalitis.	  Currently,	  no	  therapeutics	  are	  available	  that	  eliminate	  latent	  HSV-­‐1	  infection	  or	  completely	  inhibit	  viral	  reactivation	  events.	  Development	  of	  more	  effective	  therapeutics	  to	   prevent	   HSV-­‐1	   reactivation	   and	   recurrent	   disease	   has	   been	   hindered	   by	   a	   lack	   of	  understanding	  of	   the	   immune	  mechanisms	  involved	  in	  maintaining	  viral	   latency	  and	  how	  they	  are	  controlled.	  CD8+	  T	  cells	  are	  known	  to	  play	  multiple	  direct	  roles	  in	  preventing	  viral	  reactivation	   during	   latent	  HSV-­‐1	   infection,	   but	   a	   functional	   role	   for	   CD4+	   T	   cells	   has	   not	  been	  established.	  Our	  current	  hypothesis	  is	  that	  CD4+	  T	  cells	  present	  in	  the	  latent	  HSV-­‐
1-­‐infected	  TG	  are	  a	  virus-­‐specific,	  locally-­‐activated	  population	  that	  regulates	  CD8+	  T	  
cell	   function	   through	   secretion	   of	   cytokines,	   such	   as	   IL-­‐10	   and	   IFN-­‐γ,	   thereby	  
influencing	  HSV-­‐1	  latency.	  Here,	  we	  provide	  data	  indicating	  that	  at	  least	  a	  portion	  of	  the	  CD4+	  T	  cells	  in	  the	  TG	  during	  latency	  are	  HSV-­‐specific	  and	  that	  they	  localize	  to	  defined	  APC	  populations	   in	   the	   latently	   infected	   TG.	   Our	   data	   also	   indicate	   that	   the	   numbers	   and	  functionality	  of	  CD8+	  T	  cells	  that	  are	  specific	  for	  subdominant	  HSV-­‐1	  epitopes	  are	  regulated	  at	  least	  in	  part,	  by	  CD4+	  T	  cells,	  through	  an	  IL-­‐10-­‐dependent	  mechanism.	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1.0	  INTRODUCTION	  	  
1.1	  HERPES	  SIMPLEX	  VIRUS	  TYPE	  I	  (HSV-­‐1)	  
1.1.1	  Epidemiology	  and	  Pathogenesis	  
	  Herpes	   Simplex	   Virus	   1	   (HSV-­‐1)	   is	   a	   neurotropic	   viral	   pathogen	   that	   infects	   and	   resides	  within	   its	   host	   for	   the	  duration	  of	   the	  host’s	   lifetime.	  While	   humans	   are	   its	   natural	   host,	  HSV-­‐1	  exhibits	  broad	   infectivity	   for	  numerous	  mammalian	  species	   including	  mice,	  guinea	  pigs,	  and	  rabbits.	  The	   infectivity	  of	  HSV-­‐1	   in	  human	  populations	   is	  evidenced	  by	  the	  high	  percentages	  of	  seropositive	  individuals	  worldwide.	  In	  the	  United	  States,	  greater	  than	  50%	  of	  adults	  18	  years	  and	  older	  are	   seropositive	   for	  HSV-­‐1	  and	   that	  percentage	   increases	   to	  over	  90%	  in	  adults	  in	  the	  60	  and	  older	  population	  [1-­‐3].	  Globally	  it	  is	  estimated	  that	  80%	  of	  adults	  are	  infected	  with	  HSV-­‐1	  with	  seroprevalence	  increasing	  to	  98%	  in	  some	  regions	  [4-­‐6].	   Many	   seropositive	   individuals	   are	   asymptomatic	   and	   do	   not	   experience	   pathologies	  commonly	   associated	  with	   orofacial	  HSV-­‐1	   infection,	   such	   as	   cold	   sores	   or	   inflammatory	  keratitis	   events.	   However,	   a	   small	   but	   significant	   proportion	   of	   infected	   individuals	  manifest	   severe	   pathologies,	   including	   viral	   encephalitis	   and	   blinding	   stromal	   keratitis.	  Annually,	   the	   eyesight	   of	   nearly	  4,000	  patients	   is	   sight	   impaired	  due	   to	   stromal	   keratitis	  and	  HSV-­‐1-­‐induced	  keratitis	  is	  the	  leading	  infectious	  cause	  of	  blindness	  in	  the	  United	  States	  [7,	  8].	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Ocular	  infection	  of	  HSV-­‐1	  begins	  with	  a	  primary	  lytic	  infection	  phase	  within	  the	  corneal	  epithelium	  in	  which	  the	  HSV-­‐1	  genome	  is	  replicated	  and	  progeny	  virus	  is	  produced.	  During	  primary	  infection	  HSV-­‐1	  infects	  the	  sensory	  neurons	  innervating	  the	  cornea	  and	  travels	  to	  the	   trigeminal	   ganglia	   (TG)	  via	   retrograde	   transport	   [9].	  Once	   in	   the	  TG,	   retention	  of	   the	  HSV-­‐1	  genome	  in	  a	  non-­‐replicative	  state	  within	  the	  neuronal	  nuclei	  establishes	  a	  non-­‐lytic	  state	  known	  as	  latency	  [10].	  Reactivation	  of	  HSV-­‐1	  from	  latent	  infection	  frequently	  results	  in	  anterograde	  transport	  of	  the	  virus	  to	  the	  eye	  followed	  by	  HSV-­‐1	  replication	  and	  shedding	  of	   progeny	   virus	   at	   the	   corneal	   surface	   [11,	   12].	   This	   release	   of	   progeny	   virus	   can	   be	  asymptomatic	   or	   can	   cause	   epithelial	   keratitis	   or	   HSV	   endotheliitis,	   which	   is	   clinically	  characterized	   by	   painful,	   red,	  watery	   eyes	   and	   blurred	   vision	   [11,	   13].	   A	   combination	   of	  increased	   vascularization	   and	   inflammation	   in	   the	   cornea,	   sensory	   nerve	   damage,	   and	  corneal	   desiccation	   are	   characteristic	   of	   the	   progression	   of	   epithelial	   keratitis	   to	   a	  more	  severe	  state	  of	  eye	  disease	  known	  as	  Herpes	  Stromal	  Keratitis	  (HSK).	  HSK	  is	  characterized	  by	   corneal	   opacity,	   edema,	   and	   severe	   neovascularization	   of	   and	   a	   pronounced	   immune	  infiltrate	  within	  the	  stroma	  [14].	  A	  representative	  image	  of	  HSK	  in	  a	  C57BL/6	  mouse	  eye	  is	  shown	  in	  Figure	  1.	  HSK	  events	  can	  cause	  variable	  amounts	  of	  scarring	  of	  the	  cornea	  and	  when	  recurrent,	  often	  cause	  blindness	  in	  the	  infected	  eye	  [13,	  14].	  The	  molecular	  causes	  of	  HSV-­‐1	   reactivation	   remain	   unclear,	   but	   physical,	   hormonal,	   and	   psychological	   stress	   are	  associated	   with	   reactivation	   in	   humans	   and	   have	   been	   shown	   to	   cause	   reactivation	   in	  mouse	  models	  of	  HSV-­‐1	  infection	  [15-­‐19].	  	  There	   is	   currently	  no	  vaccine	   to	  prevent	  HSV-­‐1	   infection	  or	   reactivation	   from	   latency	  [11,	   20,	   21]	   and	   antiviral	   therapeutics	   are	   predominantly	   limited	   to	   DNA	   synthesis	  inhibitors	   that	   selectively	   impede	  viral	   replication,	   such	  as	   acyclovir	   [22].	  Given	   the	  high	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seroprevalence	  of	  HSV-­‐1	  and	  the	  relatively	  high	  rates	  of	  blindness	  caused	  by	  complications	  associated	  with	  ocular	  HSV-­‐1	   infection,	   the	  need	   for	   improved	  anti-­‐HSV-­‐1	   therapeutics	   is	  apparent.	  	  	  
	  
Figure	  1.	  HSK	  in	  C57BL/6	  mice.	  	  Image	  in	  left	  panel	  shows	  the	  eye	  of	  a	  healthy,	  non-­‐infected	  C57BL/6	  mouse.	  Image	  on	  right	  shows	  HSK	   in	   the	   eye	   of	   a	   C57BL/6	  mouse	   following	   infection	   with	   1X105	   PFU	   HSV-­‐1-­‐RE	   virus.	   Blood	  vessels	  have	  infiltrated	  the	  normally	  avascular	  cornea	  and	  a	  dessication-­‐induced	  epithelial	  lesion	  is	  visible.	   Figure	   graciously	   provided	   by	   Hongmin	   Yun,	   M.D.	   Eye	   and	   Ear	   Institute,	   University	   of	  Pittsburgh	  Medical	  Center,	  Pittsburgh,	  PA.	  	  
1.1.2	  HSV-­‐1	  Classification,	  Structure,	  and	  Lytic	  Replication	  Cycle	  
	  
	  HSV-­‐1	   is	   a	   double-­‐stranded	   DNA	   virus	   or	   a	   type	   I	   virus	   by	   the	   Baltimore	   Classification	  system.	  HSV-­‐1	  is	  a	  member	  of	  the	  Herpesviridae	  family	  of	  viruses	  and	  is	  further	  classified	  as	  a	   member	   of	   the	   neurotropic	   Alphaherpesvirinae	   subfamily	   along	   with	   Herpes	   Simplex	  Virus	  Type	  II	  (HSV-­‐2),	  Varicella	  Zoster	  Virus	  (VZV),	  and	  other	  members	  of	  the	  Mardivirus	  and	   Iltovirus	   genera	   [11].	   The	  HSV-­‐1	   virion	   is	   comprised	   of	   4	  major	   structurally	   distinct	  components	   (Figure	   2).	   The	   innermost	   component	   is	   the	  double-­‐stranded	  DNA	  genome,	  which	  is	  152kb	  in	   length	  and	  encodes	  84	  proteins	  [10].	   	  Encasing	  the	  viral	  genome	  is	  the	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capsid,	  an	  icosahedral	  structure	  composed	  of	  viral	  proteins	  that	  serves	  to	  protect	  the	  DNA.	  Surrounding	  the	  capsid	  shell	  is	  the	  tegument,	  which	  contains	  various	  viral	  proteins	  needed	  for	  HSV-­‐1	  to	  effectively	  infect	  and	  manipulate	  the	  host	  cell	  to	  promote	  viral	  replication	  [10,	  11].	  The	   final	   component	  of	  HSV-­‐1	   is	   the	  envelope;	  a	   lipid	  bilayer	  of	  host	   cell	  origin	   that	  surrounds	   the	   tegument	   and	   contains	   numerous	   viral	   glycoproteins	   required	   for	   viral	  egress	  and	  target	  cell	  entry	  [10,	  11,	  23].	  	  	   	  	  
	  	  	  
Figure	  2.	  Structure	  of	  the	  HSV-­‐1	  virion.	  	  Image	   in	   left	   panel:	   electron	   micrograph	   of	   an	   HSV-­‐1	   particle.	   Right	   panel:	   representative	  illustration	  of	  an	  HSV-­‐1	  particle.	  Both	  are	  labeled	  to	  show	  the	  4	  distinctive	  elements	  comprising	  the	  HSV-­‐1	  virus.	  Figure	  adapted	  from	  online	  lectures	  from	  Todar,	  K	  (2009)	  and	  Leone,	  P,	  M.D.	  	  	  	  	   	  HSV-­‐1	  enters	  its	  target	  cell	  via	  a	  fusion	  event	  mediated	  by	  HSV-­‐1	  glycoproteins	  (gB,	  gC,	  gD,	   and	   the	  gH/gL	   complex)	  binding	   to	   specific	  host	   cell	   surface	  markers	  and	   inducing	  a	  fusion	  event	  or	  by	  endocytosis[24-­‐26].	  Once	   inside	   the	  cell	   the	  viral	  capsid	   traffics	   to	   the	  nucleus	   and	   the	   HSV-­‐1	   genome	   is	   deposited	   inside.	   Viral	   gene	   expression	   ensues	   to	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generate	  proteins	   required	   for	  genome	  replication.	  Once	  genome	  replication	   is	   inititated,	  structural	  proteins	  are	  generated	  and	  viral	  capsids	  are	  assembled	  within	  the	  nucleus.	  The	  capsids	  pass	  through	  the	  nuclear	  membrane	  before	  entering	  the	  Golgi	  Network,	  where	  they	  acquire	  tegument	  proteins	  as	  well	  as	  their	  lipid	  bilayer.	  They	  completed	  viral	  particle	  then	  escapes	  the	  cell,	  compromising	  the	  cell	  membrane	  and	   inducing	   lysis	  and	  host	  cell	  death.	  The	  progeny	  virus	  will	   continue	   this	   lytic	   replication	  pattern	   in	  additional	  epithelial	  cells	  and	  will	   infect	   innervating	  neuronal	   cells.	   The	  primary	   infection	   is	   cleared	  by	   the	   innate	  immune	  system	  within	  4-­‐5	  days.	  Following	  clearance	  of	  the	  primary	  infection	  in	  the	  cornea,	  HSV-­‐1	  establishes	  a	   latent	  and	  non-­‐lytic	  stage	  of	   infection	   in	  the	  nuclei	  of	  neurons	  within	  the	  TG.	  	  
1.2	  HSV-­‐1	  LATENCY	  
1.2.1	  HSV-­‐1	  Gene	  Expression	  During	  Latency	  
	  
	  Upon	  the	  establishment	  of	  latency	  in	  the	  sensory	  ganglia,	  lytic	  gene	  expression	  is	  silenced	  and	  no	  viral	  particle	  production	  is	  observed	  [9].	  The	  HSV-­‐1	  genome	  is	  retained	  within	  the	  nuclei	  of	  infected	  sensory	  neurons	  as	  an	  episomal	  structure	  that	  is	  associated	  with	  cellular	  histones	  and	  is	  highly	  heterochromatic	  [27,28].	  Latency	  Associated	  Transcripts	  (LATs)	  are	  the	  only	  readily	  detectable	  gene	  products	  expressed	  during	   latent	  HSV-­‐1	   infections.	  LATs	  are	   non-­‐5’-­‐capped,	   non-­‐polyadenylated	   RNA	   transcripts	   that	   are	   not	   translated	   into	  functional	   proteins.	   Unlike	   lytic	   genes	   of	   the	   HSV-­‐1	   genome,	   the	   LAT	   locus	   is	   highly	  acetylated	  and	  organized	  into	  euchromatin	  during	  latency,	  which	  favors	  it	  expression	  [29].	  LATs	  are	  present	  in	  humans	  and	  in	  animals	  latently	  infected	  with	  HSV-­‐1	  [30-­‐33]	  and	  have	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long	  been	  the	  focus	  of	  studies	  aimed	  at	  understanding	  the	  molecular	  mechanisms	  of	  HSV-­‐1	  latency.	  Until	   recently,	   it	   was	   believed	   that	   there	  was	   no	   HSV-­‐1	   lytic	   gene	   expression	   during	  latent	   infection.	   Indeed,	   researchers	   have	   yet	   to	   successfully	   isolate	   any	   HSV-­‐1	   protein	  product	  from	  the	  latently	  infected	  mouse	  or	  human	  sensory	  ganglia.	  However,	  transcripts	  for	   the	   HSV-­‐1	   beta	   (β)	   genes,	   Infected	   Cell	   Proteins	   0	   and	   4	   (ICP0,	   ICP4),	   have	   been	  detected	   in	   human	   TGs	   harboring	   latent	   HSV-­‐1	   infection	   [34-­‐36]	   and	   these	   levels	   are	  increased	   in	   the	   absence	   of	   LAT	   expression	   [37].	   The	  discovery	   of	  HSV-­‐1	   alpha	   (α)	   gene	  products	   in	   latently	   infected	   human	   TGs	   calls	   into	   question	   the	   generally	   accepted	  paradigm	  that	  LATs	  are	   the	  only	  HSV-­‐1	  gene	  product	   to	  be	  expressed	  during	   latency	  and	  indicates	   that	   low	   levels	   of	   lytic	   gene	   expression	   may	   also	   occur.	   This	   hypothesis	   is	  supported	  by	  the	  observation	  that	  HSV-­‐specific	  CD8+	  T	  cells	  present	  in	  the	  latently	  infected	  TG	  preferentially	  surround	  neurons	  positive	  for	  ICP0	  and	  LAT	  transcripts	  when	  compared	  to	  neurons	  positive	  for	  LAT	  alone	  [36].	  However,	  positive	  identification	  of	  lytic	  transcripts	  in	  the	  infected	  TG	  may	  simply	  indicate	  that	  a	  reactivation	  event	  is	  ensuing	  and	  that	  latency	  has	  been	  compromised.	  More	  studies	  are	  needed	   to	  determine	   if	  HSV-­‐1	  protein	  products	  are	   generated	  during	   latency	   and,	   if	   so,	   how	   this	   expression	   influences	   cellular	   and	   viral	  factors	  that	  maintain	  quiescence.	  
1.2.2	  Immune	  Control	  of	  Latent	  HSV-­‐1	  Infection	  
	  Latent	  HSV-­‐1	  infection	  has	  long	  been	  viewed	  as	  a	  silent	  infection	  that	  is	  largely	  ignored	  by	  the	  immune	  system.	  However,	  this	  view	  is	  shifting	  as	  data	  published	  in	  the	  last	  2	  decades	  indicate	   that	   latent	   HSV-­‐1	   infection	   is	   dynamic.	   Numerous	   lytic	   genes	   are	   expressed	   in	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addition	  to	  LATs	  during	  latent	  HSV-­‐1	  infection	  [33,	  38,	  39]	  and	  cells	  of	  the	  immune	  system	  are	  present	  and	  active	  in	  preventing	  viral	  reactivation	  in	  the	  TG	  [39-­‐44].	  The	  evidence	  for	  persistent	   HSV-­‐1	   lytic	   gene	   expression	   and	   immune	   presence	   in	   the	   TG	   combined	   with	  recently	   published	   data	   show	   high	   levels	   of	   exhaustion	   in	   some	   epitope-­‐specific	  populations	  of	  CD8+	  T	  cells	  in	  the	  latently	  infected	  TG	  have	  prompted	  the	  shift	  from	  a	  view	  of	  HSV-­‐1	  latency	  as	  a	  quiet	  infection	  to	  that	  of	  a	  persistent	  or	  chronic	  infection	  [39,	  45,	  46].	  This	  has	  far-­‐reaching	  implications	  on	  how	  best	  to	  approach	  studies	  of	  immune	  function	  in	  HSV-­‐1	  latency.	  	  
1.2.2.1	   Maintenance	   of	   Viral	   Latency	   by	   CD8+	   T	   Cells.	   CD8+	   T	   cells	   have	   been	  most	  studied	   in	   mouse	   model	   systems	   of	   latent	   HSV-­‐1	   infection	   and	   have	   thus	   far	   been	  implicated	  as	  the	  primary	  cells	  involved	  in	  preventing	  HSV-­‐1	  reactivation	  [41,	  42,	  44].	  All	  CD8+	  T	  cells	  present	  in	  the	  TG	  during	  HSV-­‐1	  latency	  are	  HSV-­‐specific	  and	  surround	  infected	  neurons	   in	   clusters	   [38,	  43,	  54].	  Expression	  of	   interferon-­‐gamma	  (IFN-­‐γ)	  by	  CD8+	  T	   cells	  has	  been	  shown	  to	  directly	  inhibit	  HSV-­‐1	  reactivation	  ex	  vivo	  by	  preventing	  transcription	  of	  the	   viral	   gene	   encoding	   ICP0	   [41].	   Additionally,	   CD8+	   T	   cells	   secrete	   non-­‐cytotoxic	  Granzyme	  B	  (GrzB),	  which	  directly	  cleaves	  ICP4,	  a	  viral	  protein	  required	  for	  transcription	  of	   early	   and	   late	   HSV-­‐1	   genes	   [42].	   The	   antigen	   specificity	   of	   TG-­‐resident	   CD8+	   T	   cells	  during	   lytic	   and	   latent	   infection	   is	   varied	   across	   19	   epitopes	   with	   50%	   of	   CD8+	   T	   cells	  recognizing	  a	  dominant	  Glycoprotein	  B	  (gB)	  epitope	  and	  the	  other	  50%	  responding	  to	  one	  of	   18	   subdominant	   epitopes	   derived	   from	   11	   unique	   HSV-­‐1	   proteins	   [40,	   45].	   Further	  examination	   of	   epitope-­‐specific	   CD8+	   T	   cell	   populations	   show	   a	   discrepancy	   in	   the	  capability	  of	  different	  HSV-­‐specific	  populations	  in	  the	  TG	  to	  prevent	  viral	  reactivation	  that	  is	  dependent,	  in	  part,	  upon	  signaling	  through	  the	  IL-­‐10	  receptor	  [45].	  Clear	  roles	  for	  HSV-­‐
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specific	  CD8+	  T	  cells	  have	  been	  defined	  in	  latent	  HSV-­‐1	  infection	  in	  B6	  mice,	  but	  the	  means	  by	  which	  CD8+	  T	  cell	  effector	  activities	  are	  regulated	  are	  not	  fully	  understood.	  	  
1.2.2.2	   CD4+	   T	   Cells	   in	   Primary	   and	   Latent	   Infection.	   CD4+	   T	   cell	   functions	   during	  primary	   viral	   infections	   are	   often	   critical	   for	   the	   development	   of	   an	   effective	   adaptive	  immune	  response.	   	   IFN-­‐γ	  secreted	  by	  CD4+	  T	  cells	   is	  required	  to	  induce	  the	  expression	  of	  chemokines	  that	  promote	  activated	  CD8+	  T	  cell	  migration	  into	  infected	  tissues	  [47].	  CD4+	  T	  cell-­‐secreted	   IL-­‐2	   is	  required	   for	  CD8+	  T	  cell	  migration	  during	   immune	  priming	   following	  LCMV	   infection	   and	   for	   CD8	   memory	   responses	   in	   chicken	   ovalbumin	   models	   of	   T	   cell	  function	  [48,	  49].	  CD4+	  T	  cells	  also	  enhance	  the	  expression	  of	  costimulatory	  molecules	  on	  the	  surface	  of	  dendritic	  cells	  (DCs)	  to	  promote	  CD8	  and	  CD4	  lymphocyte	  activation	  [50,	  51].	  In	   numerous	   models	   of	   infection,	   a	   functional	   tissue-­‐resident	   CD8+	   T	   cell	   memory	  population	  is	  not	  generated	  without	  the	  help	  of	  CD4+	  T	  cells	  early	  in	  infection	  [47-­‐51]	  and	  HSV-­‐1	  infection	  is	  no	  exception	  [52].	  This	  highlights	  the	  importance	  of	  CD4+	  T	  cell	  function	  for	  T	  cell	  priming	  and	  differentiation	  during	  the	  primary	  infection	  but	  CD4+	  T	  cell	  functions	  may	   be	   critical	   for	   immune	   regulation	   during	   chronic	   infection	   as	   well.	   During	   chronic	  lymphocytic	   choriomeningitis	   virus	   (LCMV)	   infection,	  CD4+	  T	   cells	   are	  believed	   to	  be	   the	  key	  producers	  of	  IL-­‐21,	  a	  cytokine	  that	  prevents	  functional	  CD8+	  T	  cell	  exhaustion	  [53-­‐54].	  While	   IL-­‐21	  production	  has	  yet	   to	  be	  assessed	   in	   latent	  HSV-­‐1	   infection,	  evidence	  of	  high	  levels	  of	  exhaustion	  in	  CD8+	  T	  cells	  in	  the	  TG	  during	  latent	  infection	  suggests	  this	  cytokine	  is	  not	  being	  produced	  or	  is	  being	  in	  produced	  at	  suboptimal	  levels	  [40,45].	  	  It	  is	  unclear	  if	  CD4+	  T	  cells	  present	  in	  the	  TG	  directly	  prevent	  viral	  reactivation	  but	  there	  is	  evidence	  for	  indirect	  CD4+	  T	  cell	  control	  of	  HSV-­‐1	  latency	  through	  regulation	  of	  CD8+	  T	  cell	  function.	  Indeed,	  20%	  of	  CD4+	  T	  cells	  in	  the	  latent	  HSV-­‐1-­‐infected	  B6	  TG	  express	  IL-­‐10	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and	   IL-­‐10	   appears	   to	   regulate	   the	   functionality	   of	   subdominant	   epitope-­‐specific	   CD8+	   T	  cells	  [45].	  It	  is	  also	  feasible	  that	  CD4+	  T	  cells	  may	  act	  directly	  to	  modulate	  HSV-­‐1	  latency	  in	  the	  TG	  through	  secretion	  of	  IFN-­‐γ,	  as	  is	  observed	  for	  CD4+	  T	  cells	  in	  chronic	  γ-­‐Herpesvirus	  68	  (γHV68)	  infections	  [55,	  56]	  and	  CD8+	  T	  cells	  in	  HSV-­‐1	  infection	  [44].	  CD4+	  T	  cells	  have	  also	  been	  observed	  to	  take	  on	  cytolytic	  effector	  functions	  such	  as	  FasL	  expression	  and	  GrzB	  degranulation	   in	   murine	   models	   of	   chronic	   infection	   [57,	   58],	   though	   there	   is	   not	   yet	  evidence	   indicating	   that	   this	   occurs	   in	   latent	  HSV-­‐1	   infection.	  The	   role	  of	  CD4+	  T	   cells	   in	  maintaining	   HSV-­‐1	   latency	   remains	   unclear	   and	  while	   we	   hypothesize	   that	   CD4+	   T	   cells	  indirectly	   regulate	   viral	   latency	   through	   mediation	   of	   CD8+	   T	   cell	   function,	   it	   is	   not	  unreasonable	   to	   hypothesize	   that	   CD4+	   T	   cells	  may	   also	   have	   direct	   roles	   in	   preventing	  HSV-­‐1	  reactivation. A	  portion	  of	   the	  CD4+	  T	  cells	   in	  the	  TG	  following	  HSV-­‐1	   infection	   in	  humans	  and	  mice	  are	   antigen	   specific	   [38,	   58],	   indicating	   that	   effector	   functions	   elicited	   by	   these	   cells	   are	  likely	  in	  response	  to	  viral	  antigen.	  However,	  antigen	  non-­‐specific	  CD4+	  T	  cells,	  particularly	  of	  the	  natural	  regulatory	  T	  (nTreg)	  lineage,	  are	  observed	  to	  mediate	  immune	  activity	  during	  viral	   infection	  after	  TLR-­‐2	  and	  TLR-­‐4	  stimulation	  by	  viral	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs)	  [59,	  60].	  Given	  that	  the	  lineage	  and	  cytokine	  production	  profiles	  of	  CD4+	  T	  cells	  in	  the	  latently	  infected	  TG	  have	  not	  yet	  been	  characterized,	  it	  is	  unclear	  if	  these	  cells	  are	  acting	  in	  direct	  response	  to	  viral	  antigen	  presented	  via	  MHC	  class	  II	  molecules	  on	  the	  surface	  of	  antigen	  presenting	  cells	  (APCs)	  or	  if	  they	  are	  nonspecific	  responders	  to	  infection.	  Since	   the	   identification	   of	   the	   HSV-­‐1-­‐specific	   CD8+	   T	   cell	   repertoire	   following	   HSV-­‐1	  infection	   was	   realized,	   the	   functional	   capacity	   of	   these	   cells	   has	   been	   better	   defined,	   as	  described	  above	  [40,45].	  Progress	   in	  defining	   the	   functional	  role(s)	  of	  CD4+	  T	  cells	   in	   the	  
	   10	  
modulation	  HSV-­‐1	   latency	  may	  also	  be	  possible	   through	   the	   identification	  of	   the	  antigen-­‐specific	  CD4+	  T	  cell	  repertoire.	  	  
1.2.2.3	  Antigen	  Presentation	  in	  the	  Trigeminal	  Ganglia	  (TG).	  The	  contributions	  of	  APCs	  in	   the	  maintenance	   of	   CD4	   and	   CD8	   lymphocyte	   function	   in	   the	   TG	   during	   latent	   HSV-­‐1	  infection	  have	  yet	   to	  be	  elucidated.	  However,	   the	  role	  of	  DCs	   in	  antigen	  presentation	  and	  activation	  of	  CD4	  and	  CD8	  lymphocytes	  in	  the	  spleen	  and	  lymph	  node	  after	  primary	  HSV-­‐1	  infection	   is	   well	   established	   [61-­‐66].	   It	   is	   also	   apparent	   that	   DCs	   present	   in	   previously	  infected	  non-­‐lymphoid	  tissue	  are	  capable	  of	  presenting	  antigen	  to	  initiate	  robust	  responses	  from	  effector	  and	  memory	  T	  lymphocytes	  in	  numerous	  models	  of	  viral	  infection	  including	  HSV-­‐1	  [63,	  66-­‐68],	  indicating	  the	  potential	  of	  DC	  populations	  in	  the	  TG	  to	  present	  antigen	  to	   memory	   T	   cell	   populations	   during	   latency.	   Macrophages	   are	   also	   required	   for	   the	  development	   of	   effective	   innate	   and	   adaptive	   immune	   responses	   during	   primary	   HSV-­‐1	  infection.	   Cytokines	   such	   as	   IL-­‐12	   and	   IFN-­‐γ	   are	   produced	   by	  macrophages	   early	   during	  primary	   HSV-­‐1	   infection	   to	   aid	   in	   the	   activation	   of	   the	   innate	   and	   adaptive	   immune	  responses	  [69,	  70].	  Macrophages	  are	  also	  implicated	  as	  APCs	  in	  the	  acutely	  HSV-­‐1-­‐infected	  mouse	   cornea	   [71].	   Macrophages	   infiltrate	   the	   TG	   following	   HSV-­‐1	   infection	   and	   aid	   in	  eradication	   of	   replicating	   virus	   in	   neurons	   following	   primary	   HSV-­‐1	   infection	   and	   are	  retained	   in	   the	   TG	   during	   latent	   infection	   but	   it	   remains	   unclear	   if	   they	   participate	   in	  immune	  responses	  that	  prevent	  HSV-­‐1	  reactivation	  [43,	  72].	  During	  acute	  HSV-­‐1	  infection,	  neurons	   and	   Schwann	   cells	   in	   the	   TG	   up-­‐regulate	   the	   expression	   of	  MHCI	   [73]	   and	   it	   is	  possible	  that	  they	  also	  up-­‐regulate	  MHCII,	  since	  IFN-­‐γ	  that	  is	  persistently	  expressed	  in	  the	  latently	   infected	   TG	   can	   increase	   MHCII	   expression	   on	   numerous	   cell	   types	   found	   in	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nervous	  tissue	  [74,	  75].	  As	  such,	   it	   is	  also	  possible	  that	  neurons	  and	  Schwann	  cells	  act	  as	  APCs	  to	  T	  cells	  in	  the	  TG	  during	  HSV-­‐1	  latency.	  
	  
1.3	  C57BL/6	  MOUSE	  MODEL	  OF	  INFECTION	  
	  
	  Several	  animal	  models	  are	  employed	  to	  study	  HSV-­‐1	  infection	  including	  guinea	  pig,	  rabbit,	  and	  mouse	  models	   [40,	   43,	   76-­‐78].	   In	   the	   proposed	   studies	  we	   employ	   a	   C57BL/6	   (B6)	  mouse	  model	  of	  ocular	  infection	  and	  predominantly	  utilize	  the	  HSV-­‐1-­‐KOS	  strain	  of	  virus,	  a	  well-­‐characterized	  strain	  that	  was	  originally	  isolated	  from	  infected	  human	  tissue	  [78,	  79].	  Ocular	   infection	  mimics	   a	   common	   route	   of	   infection	   in	   humans	   and	   like	   human	   HSV-­‐1	  infection;	   mice	   mount	   an	   immune	   response	   capable	   of	   clearing	   primary	   infection	  concurrent	  with	  the	  establishment	  of	  latent	  infection	  in	  the	  TG	  [39,	  78].	  Additionally,	  CD4+	  and	  CD8+	  T	  cell	  localize	  around	  infected	  neurons	  in	  the	  TG	  in	  humans	  and	  mice	  [38,	  43]	  and	  CD8+	   T	   cells	   with	   TCR	   specificity	   for	   the	   same	   HSV-­‐1	   proteins	   have	   been	   identified	   in	  infected	  mouse	   and	   human	   TGs	   [38,	   40].	   Unlike	   in	   human	   infection,	   spontaneous	  HSV-­‐1	  reactivation	  rarely	  occurs	  in	  mice	  [78]	  and	  stromal	  keratitis	  events	  are	  observed	  following	  primary	   infection	  rather	  than	  following	  a	  reactivation	  event,	  as	   is	  most	  often	  observed	   in	  humans.	  However,	  the	  application	  of	  psychological	  or	  hormonal	  stress	  to	  latently	  infected	  mice	   can	   induce	   in	   vivo	   HSV-­‐1	   reactivation,	   allowing	   for	  monitoring	   of	   events	   occurring	  during	  and	   following	  viral	  reactivation	  [18,	  80].	  As	  such,	  mouse	  models,	   including	   the	  B6	  model,	  are	  imperfect	  yet	  effective	  models	  within	  which	  to	  study	  immune	  responses	  to	  HSV-­‐1	  infection	  that	  may	  parallel	  human	  HSV-­‐1	  infection.	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Specific	   Aim	   1:	   Define	   the	   HSV-­‐1-­‐specific	   CD4+	   T	   cell	   repertoire	   in	   the	   TG	   during	  
primary	  and	  latent	  infection.	  	  
Hypothesis:	  A	  majority	  of	  CD4+	  T	  cells	  in	  the	  TG	  during	  primary	  and	  latent	  HSV-­‐1	  infection	  are	  
HSV-­‐specific	   and	   recognize	   numerous	   HSV-­‐1	   proteins,	   but	   the	   breadth	   of	   HSV-­‐1	   epitopes	  
recognized	  by	  CD4+	  T	  cells	  during	  latency	  is	  reduced	  in	  comparison	  to	  primary	  infection.	  	  
Data	   from	   our	   laboratory	   and	   others	   indicates	   that	   at	   least	   a	   portion	   of	   CD4+	   T	   cells	  
present	   in	   the	   TGs	   of	   humans	   with	   HSV-­‐1	   infection	   bear	   TCRs	   specific	   for	   HSV-­‐1	   proteins.	  
However,	   the	  HSV-­‐1	  antigens	   recognized	  by	  CD4+	  T	   cells	  present	   in	   the	  TG	   following	  HSV-­‐1	  
infection	  remain	  undefined.	  It	  is	  also	  unclear	  if	  the	  entire	  responding	  CD4+	  T	  cell	  population	  in	  
the	   TG	   is	   HSV-­‐specific	   and,	   if	   so,	   if	   this	   antigen-­‐specific	   population	   is	   proportionately	  
maintained	  in	  latent	  HSV-­‐1	  infection	  and	  has	  function	  in	  preventing	  HSV-­‐1	  reactivation	  in	  the	  
TG.	  	  
	   	  
Specific	   Aim	   2:	   Identify	   the	   cell	   population(s)	   CD4+	   T	   cells	   interact	  with	   in	   the	   TG	  
during	  latent	  HSV-­‐1	  infection	  and	  determine	  if	  these	  cell	  populations	  are	  MHCII+	  and	  
capable	  of	  activating	  CD4+	  T	  cells	  ex	  vivo	  in	  the	  presence	  of	  HSV-­‐1	  proteins.	  
Hypothesis:	  CD4+	  T	  cells	  interact	  with	  MHCII+	  APC	  populations	  within	  the	  HSV-­‐1-­‐infected	  TG	  
and	  these	  MHCII+	  populations	  are	  capable	  of	  eliciting	  a	  cytokine	  response	  from	  CD4+	  T	  cells	  
when	  HSV-­‐1	  antigen	  is	  present.	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Numerous	   models	   of	   HSV	   infection	   have	   indicated	   that	   MHCII+	   APC	   populations	   can	  
activate	   CD4+	   T	   cells	   in	   an	   antigen-­‐specific	   manner	   in	   peripheral	   non-­‐lymphoid	   tissues.	  
However,	   it	   remains	   unclear	   if	   CD4+	   T	   cells	   are	   activated	   by	   cognate	   antigen	   in	   the	   TG	  
following	  HSV-­‐1	  infection	  as	  MHCII+	  populations	  and	  CD4+	  T	  cell:cell	   interactions	  within	  the	  
TG	  have	  yet	  to	  be	  fully	  defined.	  
	  
Specific	  Aim	  3:	  Determine	  if	  CD4+	  T	  cells	  are	  the	  sole	  source	  of	  IL-­‐10	  in	  the	  latently	  
infected	   TG	   and	   if	   their	   presence	   is	   required	   for	   enhanced	   CD8+	   T	   cell	   function	   in	  
vivo.	  
Hypothesis:	   CD4+	   T	   cells	   are	   a	   major,	   though	   perhaps	   not	   sole,	   source	   of	   IL-­‐10	   in	   TGs	  
harboring	   latent	  HSV-­‐1	   infection	  and	   their	  presence	   in	   the	  TG	  during	   latency	   is	   required	   to	  
mediate	  CD8+	  T	  cell	  function	  and	  modulate	  HSV-­‐1	  reactivation.	  
Approximately	  20%	  of	  CD4+	  T	  cell	  present	  in	  the	  latently	  infected	  TG	  express	  IL-­‐10.	  IL-­‐10	  
has	   a	   significant	   effect	   on	   the	   number	   and	   functionality	   of	   HSV-­‐1	   subdominant	   epitope-­‐
specific	  CD8+	  T	  cells	  as	  well	  as	  on	  HSV-­‐1	  reactivation	  within	  the	  latently	  infected	  TG.	  However,	  
it	   is	  unclear	  if	  the	  effects	  of	  IL-­‐10	  on	  CD8+	  T	  cells	  are	  CD4-­‐derived	  as	  examination	  of	  CD8+	  T	  
cell	  function	  in	  the	  TG	  upon	  latent	  depletion	  of	  CD4+	  T	  cells	  has	  yet	  to	  be	  examined.	  It	  is	  also	  
unclear	  if	  CD4+	  T	  cells	  are	  the	  sole	  source	  of	  IL-­‐10	  within	  the	  TG	  during	  latent	  HSV-­‐1	  infection	  
or	  if	  additional	  immune	  cell	  populations	  secrete	  IL-­‐10	  to	  regulate	  CD8+	  T	  cell	  function.	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3.0	  GENERAL	  MATERIALS	  AND	  METHODS	  	  	  
3.1	  MICE	  
	  
	  Female	  6–8	  week	  old	  WT	  C57BL/6	  mice	  were	  purchased	  from	  The	  Jackson	  Laboratory	  (Bar	  Harbor,	   ME).	   B6.129S6-­‐Il10tmlFlv/J	   mice	   (IL-­‐10-­‐GFP	   mice)	   were	   kindly	   provided	   by	   Dr.	  Francis	  Carbone,	  University	  of	  Melbourne	  and	  were	  bred	  in	  house	  following	  their	  receipt.	  B6.Cg-­‐Gt(ROSA)26Sortm14(CAG-­‐tdTomato)Hze/J	   (ROSA)	  mice	  were	   purchased	   from	   The	   Jackson	  Laboratory	  and	  were	  bred	  in	  house	  upon	  their	  receipt.	  All	  experimental	  animal	  procedures	  were	  reviewed	  and	  approved	  by	  the	  University	  of	  Pittsburgh	  Institutional	  Animal	  Care	  and	  Use	  Committee,	  and	  the	  animals	  were	  handled	  in	  accordance	  with	  guidelines	  established	  by	  Institutional	  Animal	  Care	  and	  Use	  Committee	  (IACUC).	  	  
3.2	  VIRUS	  AND	  CORNEAL	  INFECTIONS	  
	  
	  HSV-­‐1-­‐KOS	   strain	  was	   grown	   in	   Vero	   cells	   and	   intact	   virions	  were	   isolated	   on	   Optiprep	  gradients	  according	   to	   the	  manufacturer’s	   instructions	   (Accurate	  Chemical	   and	  Scientific,	  Westbury,	   NY).	   HSV-­‐1-­‐SV40-­‐Cre	   (F	   Strain)	   virus	   was	   generously	   provided	   by	   Bernard	  Roizman	   (University	   of	   Chicago,	   Chicago,	   Illinois)	   and	   was	   grown	   in	   Vero	   cells.	   Intact	  virions	   were	   isolated	   in	   Optiprep	   gradients	   as	   per	   manufacturer’s	   protocol	   (Accurate	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Chemical	  and	  Scientific,	  Westbury,	  NY).	  Mice	  were	  anesthetized	  by	  i.p.	   injection	  of	  2.5	  mg	  ketamine	  hydrochloride	  and	  0.25	  mg	  xylazine	  (Phoenix	  Scientific,	  San	  Marcos,	  CA)	  in	  0.25	  ml	   HBSS	   (BioWhittaker,	   Walkersville,	   MD).	   Mice	   received	   bilateral	   topical	   infection	   on	  scarified	  corneas	  with	  a	  dose	  of	  1	  X	  105	  PFU/eye	  unless	  otherwise	  noted	  in	  text.	  	  
3.3	  TISSUE	  PREPARATION	  
	  Anesthetized	  mice	  (2.5mg	  ketamine	  hydrochloride	  and	  0.25mg	  xylazine,	  i.p.)	  were	  injected	  with	   0.3ml	   heparin	   (100U/ml)	   and	   euthanized	   by	   exsanguination.	   TGs	  were	   excised	   and	  digested	  at	  37°C	  in	  100ul/TG	  of	  DMEM	  containing	  0.02U	  Liberase	  (Roche,	  Indianapolis,	  IN)	  for	  1	  hour	  before	  being	  triturated	   into	  single-­‐cell	  suspensions	  through	  the	  use	  of	  a	  200ul	  pipette	   tip.	   Spleens	  were	  mechanically	   dissociated	   through	   a	   40μm	  nylon	   screen	   (Fisher	  Scientific,	   Fair	   Lawn,	   NJ)	   and	   were	   depleted	   of	   red	   blood	   cells	   (RBCs)	   by	   a	   3-­‐minute	  incubation	   with	   1X	   RBC	   lysis	   buffer	   (0.16M	   NH4Cl	   (Fisher)	   dissolved	   in	   distilled	   water)	  prior	  to	  their	  use.	  	   	  
3.4	  REAGENTS	  FOR	  FLOW	  CYTOMETRY	  AND	  FLUORESCENT	  IMAGING	  
	  APC-­‐conjugated	   H-­‐2Kb	   tetramers	   conjugated	   to	   the	   gB498-­‐505	   peptide	   provided	   by	   the	  National	   Institute	   of	   Allergy	   and	   Infectious	   Disease	   Tetramer	   Core	   Facility	   (Emory	  University	  Vaccine	  Center,	  Atlanta,	  GA).	  CD45-­‐PerCP,	  CD8-­‐PacBlue,	  CD4-­‐PacBlue,	  CD8-­‐APC-­‐Cy7,	   CD4-­‐PE,	   IFN-­‐γ-­‐PE-­‐Cy7,	   and	   IL-­‐10-­‐APC	   antibodies	   as	   well	   as	   FcBlock,	  Cytofix/Cytoperm,	   and	   Perm	  Wash	  were	   purchased	   from	   BD	   Biosciences	   (San	   Jose,	   CA).	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CD3-­‐APC-­‐eF780,	   CD4-­‐FITC,	   and	   IL-­‐4-­‐AF647	   antibodies	   were	   purchased	   from	   Biolegend	  (San	  Diego,	  CA).	   IL-­‐17-­‐PE,	  GrzB-­‐PE,	  CD4-­‐APC,	  F4/80-­‐APC,	  and	  F4/80-­‐APC-­‐Cy7	  antibodies	  were	  purchased	  from	  eBioscience	  (San	  Diego,	  CA).	  Live/Dead-­‐Aqua	  staining	  kit	  purchased	  from	   Life	   Technologies	   (Grand	   Island,	   NY).	   NeuN-­‐AF488	   antibody	   purchased	   from	  Millipore	  (Billerica,	  MA).	  Mouse	  anti-­‐GS	  primary	  and	  goat	  anti-­‐mouse	  secondary	  antibodies	  purchased	   from	  Invitrogen	  (Grand	  Island,	  NY).	  All	  extracellular	  stains	  generated	  received	  Fc	   Block	   at	   a	   1:50	   dilution.	   All	   flow	   cytometry	   samples	   collected	   on	   a	   FACSAria	   sorting	  cytometer	   and	   analyses	   conducted	   in	   FlowJo	   Software	   (Tree	   Star,	   Ashland,	   OR).	   All	  statistics	  generated	  in	  Graphpad	  Prism	  software	  (LaJolla,	  CA)	  or	  Microsoft	  Excel	  (Redmond,	  WA).	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4.0	  ANTIGEN	  SPECIFICITY	  OF	  CD4+	  T	  CELLS	  IN	  THE	  TG	  AND	  SPLEEN	  DURING	  ACUTE	  
AND	  LATENT	  HSV-­‐1	  INFECTION	  	  	  
4.1	  INTRODUCTION	  
	  We	   have	   previously	   defined	   the	   HSV-­‐specific	   CD8+	   T	   cell	   repertoire	   in	   the	   TG	   following	  ocular	   infection	  of	  B6	  mice	  and	   it	  has	  been	  determined	  that	  all	  CD8+	  T	  cells	   in	  TG	  during	  primary	  and	  latent	  infection	  are	  HSV-­‐specific	  [40,	  Sarah	  Bidula,	  personal	  communication].	  Recently,	  CD4+	  T	  cells	  specific	  for	  HSV-­‐1	  proteins	  ICP47	  &	  VP16	  were	  identified	  in	  HSV-­‐1-­‐infected	   human	  TG	   samples	   [38]	   and	   numerous	   studies	   have	   indicated	   that	   a	   portion	   of	  CD4+	  T	  cells	  responding	  to	  HSV-­‐1	  infection	  have	  antigen	  specificity	  for	  HSV-­‐1	  glycoprotein	  D	  (gD)	  [81-­‐84].	   	  Given	  these	  observations,	  we	  postulate	  that	  a	  majority	  of	  CD4+	  T	  cells	   in	  the	  TG	  during	  acute	  infection	  are	  HSV-­‐1	  specific	  and	  that	  this	  specificity	  is	  also	  observed	  in	  latency	   but	   spans	   fewer	   HSV-­‐1	   epitopes,	   as	   is	   observed	   following	   LCMV	   infection	   [85].	  Here,	  we	  describe	   results	   from	   initial	   experiments	   investigating	   the	  antigen	  specificity	  of	  CD4+	  T	  cells	  in	  the	  TG	  following	  HSV-­‐1	  infection.	  	  
4.2	  MATERIALS	  AND	  METHODS	  
4.2.1	  Preparation	  of	  splenic	  APCs	  for	  CD4+	  T	  cell	  stimulations	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Spleens	   from	   naïve	   B6	   mice	   were	   harvested	   and	   processed	   into	   single	   cell	   suspensions	  before	  CD4+	  and	  CD8+	   cells	  were	   removed	  by	  positive	   selection	  using	   the	  EasySep	   (Stem	  Cell	   Technologies,	   Vancouver,	   BC)	   CD4	   and	   CD8	   positive	   selection	   kits	   as	   per	  manufacturer’s	  protocol.	  Remaining	  splenic	  cells	  were	  plated	  in	  8ml	  sterile	  culture	  media	  in	  a	  T175	  flask	  before	  UV-­‐inactivated	  HSV-­‐1-­‐KOS	  virus	  was	  added	  at	  an	  MOI	  of	  3.	  After	  1	  hour,	  0.3ug/ml	  LPS,	  0.12μg/ml	  TNF-­‐α,	  and	  12ug/ml	  GM-­‐CSF	  were	  added	  to	  the	  flask	  and	  it	  was	  placed	  back	  in	  the	  37°C	  incubator	  overnight.	  The	  next	  morning,	  cells	  were	  harvested	  from	  culture	  flask	  by	  scraping	  and	  kept	  on	  ice	  prior	  to	  use.	  
4.2.2	  Ex	  vivo	  CD4+	  T	  cell	  stimulations	  	  
	  WT	  female	  C57BL/6	  mice	  were	  bilaterally	   infected	  with	  HSV-­‐1-­‐KOS	  virus.	  At	   time	  points	  indicated,	   spleens	  and	  TGs	  were	  harvested	  and	  dispersed	   into	   single	   cell	   suspensions.	   In	  Figures	  3,	  4	  and	  6,	  both	  TGs	   from	  each	  mouse	  were	  pooled	  and	  plated	   in	  96-­‐well	   round-­‐bottom	  plates	  (0.5	  TG/well)	  in	  100ul	  culture	  media	  (RPMI,	  1%	  penicillin-­‐streptomycin,	  1%	  L-­‐glutamine,	   10%	   fetal	   bovine	   serum,	   1%	   HEPES,	   1%	   Sodium	   pyruvate,	   1%	   Essential	  Amino	  Acids).	  To	  stimulate	  CD4+	  T	  cells,	  one	  of	  the	  following	  was	  added	  to	  each	  well:	  1)	  1ul	  Leukocyte	   Activation	   Cocktail	   (LAC)	   containing	   Golgi	   Plug	   (BD),	   2)	   1	   X	   105	  splenic	   APCs	  pulsed	   with	   whole	   UV-­‐inactivated	   HSV-­‐1-­‐KOS	   and	   2ul	   Golgi	   Plug	   (Brefeldin	   A)	   (BD),	   3)	  1X105	   non-­‐pulsed	   splenic	   APCs,	   or	   4)	   100μl	   of	   a	   100μM	   gD	   peptide	   stock	  (IPPNWHIPSIQDA,	  Invitrogen).	  Cultures	  were	  placed	  in	  37°C,	  5%	  CO2	  incubator	  for	  6	  hours	  before	  cells	  were	  washed	  in	  1X	  PBS	  and	  FACS	  buffer	  (1X	  PBS,	  1%	  FBS,	  0.1%	  Sodium	  Azide)	  and	  stained	  for	  viability	  and	  with	  a	  combination	  of	  the	  following	  antibodies:	  CD45-­‐PerCP,	  CD3-­‐e450	  or	  APC-­‐efluor780,	  CD8-­‐PacBlue	  or	  -­‐FITC,	  and	  CD4-­‐PE	  or	  -­‐FITC.	  TGs	  were	  washed	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in	  FACS	  buffer	  and	  fixed	  in	  100μl	  Cytofix/Cytoperm	  (BD)	  before	  being	  washed	  in	  1X	  Perm	  Wash	   (BD)	   and	   intracellularly	   stained	   for	   IFN-­‐γ-­‐PE-­‐Cy7	   and	   IL-­‐10-­‐APC.	   In	   Figure	   3,	   a	  separate	   sample	  of	   stimulated	   cells	  was	   stained	  with	   IL-­‐4-­‐APC	  and	   IL-­‐17-­‐PE.	  All	   staining	  and	  fixation	  steps	  were	  carried	  out	  for	  30	  minutes	  at	  4°C	  in	  the	  dark	  and	  cells	  were	  washed	  and	  assessed	  by	  flow	  cytometry.	  In	   Figure	   5,	   HSV-­‐1-­‐infected	   B6	   spleens	  were	   harvested	   and	   processed	   into	   singe	   cell	  suspensions	   at	   time	   points	   indicated	   and	   1X106	   cells	   from	   each	   sample	  were	   plated	   per	  well	   in	   round-­‐bottomed	   96-­‐well	   plates.	   Ten-­‐fold	   serial	   dilutions	   of	   a	   1.3mM	   gD	   peptide	  working	  stock	  were	  prepared	  in	  sterile	  culture	  media	  and	  100ul	  of	  each	  dilution	  was	  added	  to	   spleen	   cultures.	   Cells	  were	   cultured	   at	   37°C	   in	   5%	   CO2	   for	   5	   hours	   before	   cells	  were	  washed	  in	  1X	  PBS	  and	  FACS	  buffer	  and	  stained	  for	  viability	  and	  with	  anti-­‐	  CD44-­‐V450	  and	  -­‐CD4-­‐PE-­‐Cy7.	  Splenic	  cells	  were	  washed	  in	  FACS	  buffer	  and	  fixed	  in	  100μl	  Cytofix/Cytoperm	  (BD)	  before	  being	  washed	  in	  1X	  Perm	  Wash	  (BD)	  and	  intracellularly	  stained	  for	  IFN-­‐γ.	  All	  staining	  and	  fixation	  steps	  were	  carried	  out	   for	  30	  minutes	  at	  4°C	   in	  the	  dark.	  Cells	  were	  then	  washed	  in	  FACS	  buffer	  and	  assessed	  by	  flow	  cytometry.	  	  
4.3	  RESULTS	  	  With	  HSV-­‐1	   encoding	   84	   proteins,	   each	  with	   hundreds	   of	   potential	   peptide	   epitopes,	  we	  began	  by	  collaborating	  with	  Alessandro	  Sette	  &	  John	  Sidney	  (Center	  for	  Infectious	  Disease,	  Allergy,	  &	  Asthma	  Research,	  La	  Jolla	  Institute	  for	  Allergy	  &	  Immunology,	  San	  Diego,	  CA)	  to	  identify	  the	  top	  4%	  of	  HSV-­‐1	  peptides	  based	  on	  those	  predicted	  to	  bind	  H-­‐2	  Iab	  molecules.	  The	   IEDB	   consensus	   algorithm	  was	   used	   to	   scan	   the	   HSV-­‐1	   proteome	   (GI	   9629378)	   for	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peptides	  predicted	  to	  bind	  class	  II	  MHC	  molecules	  with	  high	  affinity.	  These	  peptides	  were	  generated	  for	  use	  in	  ex	  vivo	  CD4+	  T	  cell	  stimulation	  assays	  designed	  to	  identify	  HSV-­‐specific	  clones	  by	  their	  cytokine	  production	  after	  incubation	  with	  APCs	  pulsed	  with	  the	  peptides.	  	  Initially,	  polyclonal	  stimulation	  of	  CD4+	  T	  cells	  in	  the	  TGs	  of	  HSV-­‐1-­‐infected	  B6	  mice	  was	  performed	   to	   establish	   an	   appropriate	   readout	   for	   our	   intracellular	   cytokine	   assay.	   We	  anticipated	  that	  CD4+	  T	  cells	  present	  in	  the	  TG	  would	  predominantly	  express	  the	  T	  helper	  cell	  1	  (Th1)-­‐associated	  cytokine	  IFN-­‐γ,	  as	  is	  commonly	  observed	  in	  viral	  infection.	  Indeed,	  after	  6	  hours	  in	  culture	  with	  PMA	  and	  ionomycin,	  65-­‐75%	  of	  CD4+	  T	  cells	  isolated	  from	  the	  TGs	  of	  8	  day	  post-­‐infection	  (DPI)	  mice	  expressed	  IFN-­‐γ	  and	  a	  small	  proportion	  (15-­‐20%)	  expressed	  IL-­‐10	  (Figure	  3A-­‐C,	  G-­‐I).	  Expression	  of	  IL-­‐17	  and	  IL-­‐4,	  associated	  with	  Th17	  and	  Th2	   lineages,	   respectively,	   was	   not	   observed	   (data	   not	   shown).	   Increased	   expression	   of	  	  IFN-­‐γ	  or	  IL-­‐10	  expression	  was	  not	  observed	  in	  CD4+	  T	  cells	  from	  non-­‐infected	  TG	  samples	  after	  incubation	  with	  PMA	  and	  ionomycin	  (Figure	  3,	  D-­‐F,	  J-­‐L).	  	  
	   21	  
	  
	  
Figure	  3.	  CD4+	  T	  cells	  isolated	  from	  C57BL/6	  TGs	  during	  primary	  infection	  express	  IFN-­‐γ	  and	  
IL-­‐10	  following	  ex	  vivo	  culture	  with	  PMA	  and	  ionomycin.	  	  
	  C57BL/6	  mice	  were	  bilaterally	   infected	  with	  1X105	  PFU	  of	  HSV-­‐1-­‐KOS/eye.	  At	  8DPI	   the	  TGs	   from	  HSV-­‐infected	   and	   naïve	   mice	   were	   harvested	   and	   processed	   into	   single	   cell	   suspensions	   before	  being	  cultured	  for	  6	  hours	  in	  the	  presence	  of	  PMA	  and	  ionomycin	  and	  Golgi	  Plug.	  TG	  samples	  were	  then	   stained	   to	   analyze	   expression	   of	   CD45,	   CD3,	   CD4,	   CD8,	   IFN-­‐γ	   and	   IL-­‐10.	   (A)	   shows	   flow	  cytometry	  plots	  of	  the	  IFN-­‐γ	  expression	  in	  CD4+	  T	  cells	  from	  infected	  mice	  that	  were	  not	  stimulated	  (left)	  or	  stimulated	  with	  PMA	  and	  ionomycin	  (right).	  (B)	  &	  (C)	  show	  the	  proportion	  and	  numbers	  of	  CD4+	  T	  cells	  expressing	  IFN-­‐γ	  with	  or	  without	  stimulation.	  (D)	  shows	  flow	  cytometry	  plots	  of	  IFN-­‐γ	  expression	   in	   CD4+	   T	   cells	   from	   naïve	   mice	   with	   (right)	   or	   without	   (left)	   PMA	   and	   ionomycin	  stimulation.	   (E)	  &	   (F)	   show	  proportion	  and	  numbers	  of	  naïve	  CD4+	  T	   cells	   expressing	   IFN-­‐γ	  with	  and	   without	   PMA	   and	   ionomycin.	   (G),	   (H),	   and	   (I)	   show	   IL-­‐10	   expression	   in	   CD4+	   T	   cells	   from	  infected	  TGs	  with	   or	  without	   stimulation	   by	   PMA	   and	   ionomycin	   and	   (J),	   (K),	   and	   (L)	   shows	   the	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same	  in	  naïve	  mice.	  All	  flow	  cytometry	  plots	  shown	  were	  previously	  gated	  on	  live	  cells,	  CD45,	  and	  CD3.	   All	   bars	   represent	   the	   mean	   ±	   SEM	   of	   CD4+	   T	   cells.	   Data	   are	   representative	   of	   a	   single	  experiment	  (Infected	  mice,	  N=5,	  non-­‐infected	  mice,	  N=2).	  Statistical	  analyses	  conducted	  by	  utilizing	  student’s	  t=tests	  with	  Welch’s	  correction	  in	  GraphPad	  Prism	  6.	  ****p=0.0007,	  ***=p=0.0017.	  	  	  	   We	  then	  examined	  the	  overall	  response	  of	  CD4+	  T	  cells	   isolated	  from	  latently	   infected	  B6	   mice	   to	   HSV-­‐1.	   	   Pooled	   TGs	   were	   divided	   and	   incubated	   for	   6	   hours	   with	   PMA	   and	  ionomycin	   or	  with	   splenic	   APCs	   pulsed	  with	   UV-­‐inactivated	  HSV-­‐1-­‐KOS	   virus.	  We	   saw	   a	  similar	   proportional	   response	   from	   CD4+	   T	   cells	   cultured	   with	   PMA	   and	   ionomycin	   at	  30DPI	   as	  we	   had	   observed	   at	   8DPI	   (Figure	   3	  A-­‐C,	   G-­‐I	  and	  Figure	   4	   A-­‐D).	   CD4+	   T	   cells	  cultured	  with	   splenic	   APCs	   pulsed	  with	   UV-­‐inactivated	   HSV-­‐1-­‐KOS	   also	   expressed	   IFN-­‐γ	  and	  IL-­‐10	  following	  a	  6-­‐hour	  incubation	  period	  (Figure	  4	  A-­‐F),	  but	  IFN-­‐γ	  expression	  was	  significantly	  decreased	  in	  comparison	  to	  the	  cells	  that	  were	  stimulated	  with	  PMA	  (Figure	  4	  
A-­‐B	  and	  E).	   In	  contrast,	  IL-­‐10	  expression	  was	  moderately	  increased	  by	  HSV-­‐1	  stimulation	  relative	   to	  PMA	  stimulation	  (Figure	   4	   C-­‐D	  and	   F).	   CD4+	  T	   cells	   isolated	   from	   the	  TGs	  of	  naïve	  mice	  did	  not	  express	  IFN-­‐γ	  or	  IL-­‐10	  following	  incubation	  with	  PMA	  and	  ionomycin	  or	  HSV-­‐pulsed	  splenic	  APCs	  (data	  not	  shown).	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Figure	  4.	  CD4+	  T	  cells	   isolated	  from	  C57BL/6	  TGs	  during	  latent	   infection	  express	  IFN-­‐γ	  and	  
IL-­‐10	  following	  ex	  vivo	  culture	  with	  splenic	  APCs	  pulsed	  with	  whole	  UV-­‐inactivated	  HSV-­‐1.	  	  
	  C57BL/6	  mice	  were	  bilaterally	  infected	  with	  1X105	  PFU	  of	  HSV-­‐1-­‐KOS/eye.	  At	  30	  DPI	  the	  TGs	  from	  HSV-­‐infected	   and	   naïve	   mice	   were	   harvested	   and	   processed	   into	   single	   cell	   suspensions	   before	  being	  cultured	  for	  6	  hours	  in	  the	  presence	  of	  PMA	  and	  ionomycin	  or	  splenic	  APCs	  pulsed	  with	  UV-­‐inactivated	  HSV-­‐1-­‐KOS.	  Latently	  infected	  TG	  samples	  were	  also	  cultured	  with	  non-­‐pulsed	  APCs	  as	  a	  negative	  control.	  (A)	  &	  (B)	  show	  the	  percent	  and	  number	  of	  CD4+	  T	  cells	  expressing	  IFN-­‐γ	  after	  each	  culture	   condition.	   (C)	  &	   (D)	   show	   the	  percent	   and	  number	  of	  CD4+	  T	   cells	   expressing	   IL-­‐10	  after	  each	  culture	  condition.	  (E)	  is	  a	  representative	  flow	  plot	  of	  the	  UV-­‐HSV-­‐1	  stimulation	  data	  shown	  in	  A	  with	  non-­‐stimulated	  cells	  on	  the	  left	  and	  stimulated	  cells	  on	  the	  right.	  (F)	  shows	  the	  same	  but	  for	  IL-­‐10	   expression.	   All	   flow	   cytometry	   plots	   shown	  were	   previously	   gated	   on	   live	   cells,	   CD45,	   and	  CD3.	   All	   bars	   represent	   the	   mean	   ±	   SEM	   of	   CD4+	   T	   cells.	   Data	   is	   representative	   of	   a	   single	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experiment	   (n=5).	   Statistical	   analyses	   conducted	   using	   a	   One-­‐Way	   ANOVA	   with	   Bonferroni’s	  Multiple	  Comparison	  test	  in	  GraphPad	  Prism	  6.	  ****p<0.0001,	  **p<0.01,	  *p=<0.05.	  	   	   Much	   evidence	   has	   been	   presented	   that	   indicates	   that	   HSV-­‐1	   glycoprotein	   D	   (gD)	  generates	   peptide	   epitopes	   which	   are	   capable	   of	   stimulating	   CD4+	   T	   cell	   responses	  following	  HSV-­‐1	   infection	   [81-­‐84,	   86].	   Recently,	   a	   TCR-­‐transgenic	  mouse	   line	   specific	   for	  one	  epitope	  of	  the	  HSV-­‐1-­‐	  gD	  protein	  was	  generated	  by	  Dr.	  Andrew	  Brooks	  (University	  of	  Melbourne,	   Melbourne,	   Australia,	   personal	   communication).	   The	   T	   cells	   in	   these	   mice	  recognize	   a	   I-­‐Ab-­‐restricted	   gD	   epitope	   that	  was	   identified	   and	   sequenced	   by	   the	   Brooks	  laboratory	  group	  (unpublished	  data,	  personal	  communication).	  We	  obtained	  this	  sequence	  (IPPNWHIPSIQDA)	  and	  ordered	  the	  corresponding	  gD	  peptide	  from	  Invitrogen	  to	  examine	  the	  CD4+	  T	  cell	  response	  to	  this	  epitope	  over	  time.	  CD4+	  T	  cells	  isolated	  from	  the	  spleens	  of	  B6	  mice	   following	  HSV-­‐1infection	   responded	   to	   the	  peptide	   in	   a	   dose-­‐dependent	   fashion	  and	  persisted	  within	  the	  animals	  for	  150+	  days	  (Figure	  5).	  	  We	  also	  examined	  the	  specificity	  of	  CD4+	  T	  cells	  from	  the	  TG	  for	  their	  response	  to	  this	  gD	  peptide	  at	  8DPI.	  We	  were	  unable	  to	  detect	  IFN-­‐γ	  production	  in	  these	  cells	  after	  ex	  vivo	  culture	   and	   a	   6	   hour	   incubation	   with	   APCs	   pulsed	  with	   a	   1X10-­‐6M	   concentration	   of	   the	  peptide	  (Figure	  6,	  A-­‐C),	  a	  concentration	  that	  had	  effectively	  stimulated	  splenic	  CD4+	  T	  cells	  at	  12	  and	  150	  days	  post-­‐infection	  (Figure	  5).	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Figure	  5.	  Splenic	  CD4+	  T	  cells	  have	  specificity	  for	  HSV-­‐1	  gD	  peptide	  following	  HSV-­‐1	  infection.	  
	  C57BL/6	  mice	  were	   bilaterally	   infected	  with	   1	   X	   105	   PFU	   of	   HSV-­‐1-­‐KOS	   virus/eye.	   Spleens	   from	  infected	  mice	  were	  harvested	  12	  or	  150	  DPI	  and	  were	  dispersed	  into	  single	  cell	  suspensions	  before	  being	  cultured	  in	  the	  presence	  of	  serially	  diluted	  gD	  peptide	  for	  5	  hours.	  Cells	  were	  then	  stained	  for	  surface	   expression	   of	   CD44	   and	  CD4	   and	   intracellular	   expression	   of	   INF-­‐γ	   and	  were	   analyzed	  by	  flow	  cytometry.	  The	  percent	  of	  CD4+	  T	  cells	  expressing	   IFN-­‐γ	  at	  12	  and	  150	  DPI	   is	   shown	  above.	  Bars	   indicate	   the	   mean	   ±	   SEM.	   Data	   are	   representative	   of	   a	   single	   experiment	   (n=3/day12	   and	  4/day150).	   Standard	   student’s	   t	   tests	   were	   conducted	   in	   Microsoft	   Excel	   to	   generate	   statistics.	  
*P=0.043,	  **P<0.01.	  Figure	  adapted	  with	  permissions	  from	  data	  generated	  by	  Alexander	  M.	  Rowe,	  Ph.D.,	  Eye	  and	  Ear	  Institute,	  University	  of	  Pittsburgh	  Medical	  Center.	  Pittsburgh,	  PA.	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Figure	  6.	  CD4+	  T	  cells	  present	  in	  the	  TG	  at	  8	  DPI	  do	  not	  increase	  IFN-­‐γ	  production	  following	  
ex	  vivo	  culture	  with	  splenic	  APCs	  and	  HSV-­‐1	  gD	  peptide.	  	  
	  C57BL/6	  mice	  were	  bilaterally	   infected	  with	  1X105	  PFU	  of	  HSV-­‐1-­‐KOS/eye.	  At	  8DPI	   the	  TGs	   from	  HSV-­‐infected	   and	   naïve	   mice	   were	   harvested	   and	   processed	   into	   single	   cell	   suspensions	   before	  being	  cultured	  for	  6	  hours	  in	  the	  presence	  of	  100μl	  gD	  peptide	  and	  2μl	  Golgi	  Plug.	  TG	  samples	  were	  then	   stained	   to	   analyze	   expression	   of	   CD45,	   CD3,	   CD4,	   CD8,	   IFN-­‐γ	   and	   IL-­‐10.	   (A)	   shows	   flow	  cytometry	  plots	  of	  the	  IFN-­‐γ	  expression	  in	  CD4+	  T	  cells	  from	  infected	  mice	  that	  were	  not	  stimulated	  (left)	  or	  stimulated	  with	  gD	  peptide	  (right).	  (B)	  &	  (C)	  show	  the	  proportion	  and	  numbers	  of	  CD4+	  T	  cells	  expressing	   IFN-­‐γ	  with	  or	  without	   stimulation	  with	  gD.	  All	   flow	  cytometry	  plots	   shown	  were	  previously	  gated	  on	   live	  cells,	  CD45,	  and	  CD3.	  All	  bars	  represent	   the	  mean	  ±	  SEM	  of	  CD4+	  T	  cells.	  Data	  is	  representative	  of	  a	  single	  experiment	  (N=7).	  	  	  	  
4.4	  DISCUSSION	  AND	  FUTURE	  DIRECTIONS	  
	  A	   significant	   portion	   of	   the	   CD4+	   T	   cells	   present	   in	   the	   TG	   during	   latent	   infection	   are	  activated	  in	  response	  to	  HSV-­‐1	  ex	  vivo	  (Figure	  4),	   indicating	  that	  these	  infiltrating	  CD4+	  T	  cells	  have	  TCR	  specificity	  for	  HSV-­‐1	  peptides.	  However,	  we	  anticipated	  a	  larger	  proportion	  of	  CD4+	  T	  cells	  isolated	  from	  latently	  infected	  TGs	  would	  be	  responsive	  to	  HSV-­‐1	  ex	  vivo,	  as	  is	  observed	  for	  CD8+	  T	  cells	  [40].	  As	  such,	  we	  conducted	  numerous	  experiments	  to	  see	  if	  a	  greater	   response	   could	   be	   achieved	   following	   the	   ex	  vivo	   stimulation.	   	  We	   increased	   the	  effector	  APC	  to	  CD4+	  T	  cell	  target	  ratio,	  increased	  the	  multiplicity	  of	  infection	  (MOI)	  of	  the	  UV-­‐inactivated	  HSV-­‐1-­‐KOS	  virus	  in	  the	  APC	  cultures,	  extended	  the	  time	  of	  culture	  from	  6	  to	  10	  hours,	  and	  generated	  BMDCs	  from	  naive	  mice	  to	  serve	  as	  stimulating	  APCs	  in	  place	  of	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splenic	  APCs.	  The	  cytokine	  expression	  within	  the	  CD4+	  T	  cells	  of	   IFN-­‐γ-­‐Thy1.1	  and	  IL-­‐10-­‐GFP	  reporter	  mice	  was	  also	  examined	  following	   infection	  to	  eliminate	  the	  possibility	  that	  our	  fluorescent	  antibodies	  were	  of	  low	  specificity	  or	  affinity.	  However,	  we	  were	  unable	  to	  get	  a	  greater	  proportional	  response	  than	  is	  presented	  here.	  	  A	  future	  experiment	  examining	  the	  levels	  of	  markers	  for	  exhaustion,	  such	  as	  PD-­‐1	  and	  Tim-­‐3,	   in	   addition	   to	   cytokine	   expression	   in	   CD4+	   T	   cells	   from	   latently	   infected	   TGs	  following	   ex	   vivo	   stimulation	   should	   also	   be	   conducted.	   It	   may	   show	   that	   the	   non-­‐responsive	  CD4+	  T	  cells	  are	  exhausted,	  leaving	  open	  the	  possibility	  that	  the	  cells	  are	  HSV-­‐1-­‐specific	  but	  are	  incapable	  of	  eliciting	  effector	  functions.	  Future	  troubleshooting	  should	  also	  include	  extending	  the	  length	  of	  the	  ex	  vivo	  culture	  time	  to	  16-­‐24	  hours	  rather	  than	  6	  or	  10.	  CD4+	  T	  cells	  have	  been	  shown	  to	  require	  a	  greater	  period	  of	  exposure	  to	  antigen	  to	  become	  fully	   activated	   than	   is	   observed	   for	   CD8+	   T	   cells	   and	   extending	   the	   length	   of	   stimulation	  may	  increase	  the	  proportion	  of	   IFN-­‐γ+	  and	  IL-­‐10+	  CD4+	  T	  cells	  detected.	   It	  may	  also	  be	  of	  benefit	  to	  compare	  the	  response	  of	  CD4+	  T	  cells	  to	  whole	  UV-­‐inactivated	  virus	  to	  that	  of	  a	  Vero	   cell	   lysate	   harvested	   10	   hours	   post-­‐infection.	   The	   UV-­‐inactivated	   viruses	   used	   are	  nearly,	   but	   not	   completely,	   inactivated	   and	   thus	   may	   be	   capable	   of	   infecting	   and	  consecutively	  retarding	  efficient	  antigen	  presentation	  by	  splenic	  APCs	  or	  BMDCs	  to	  CD4+	  T	  cells.	  It	  is	  also	  feasible	  that	  CD4+	  T	  cells	  in	  the	  TG	  that	  are	  not	  activated	  in	  our	  ex	  vivo	  cultures	  may	   not	   have	   TCR	   specificity	   for	   HSV-­‐1	   peptides.	   An	   experiment	   examining	   the	   CD4+	   T	  cytokine	   response	   to	   whole	   UV-­‐inactivated	   HSV-­‐1	   in	   comparison	   to	   a	   pool	   of	   all	   of	   the	  predicted	  MHCII-­‐binding	  HSV-­‐1	  peptides	  may	  prove	  telling.	  If	  the	  magnitude	  of	  the	  ex	  vivo	  response	  of	  CD4+	  T	  cells	  to	  the	  conglomerate	  peptides	  is	  equivalent	  to	  that	  of	  CD4+	  T	  cells	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to	  whole	  virus,	   it	  may	  indicate	  that	  the	  remaining	  CD4+	  T	  cell	  population	   in	  the	  TG	  is	  not	  specifically	  responding	  to	  HSV-­‐1.	  	  While	  we	  were	  able	  to	  generate	  a	  response	  to	  the	  HSV-­‐1	  gD	  peptide	  from	  splenic	  CD4+	  T	  cells	  at	  12	  and	  150DPI,	  we	  did	  not	  observe	  cytokine	  secretion	   from	  CD4+	  T	  cells	   isolated	  from	  TGs	  in	  response	  to	  gD	  peptide	  at	  8DPI	  (Figures	  5-­‐6).	  An	  experiment	  conducted	  in	  our	  laboratory	   indicates	   that	   the	   highest	   numbers	   of	   CD4+	   T	   cells	   can	   be	   found	   in	   the	   TG	   at	  11DPI.	  The	   lack	  of	  response	  by	  CD4+	  T	  cells	   to	   the	  HSV-­‐1	  gD	  peptide	  at	  8DPI	  may	  be	   the	  result	  of	  examining	  the	  CD4	  response	  at	  a	  time	  point	  too	  early	  after	   infection	  when	  all	  of	  the	  HSV-­‐1-­‐specific	  CD4+	  T	   cell	   clones	  have	  not	  yet	  migrated	   to	   the	  TG.	  Culturing	   the	  TGs	  with	  gD	  peptide	  and	  a	  larger	  APC	  population	  than	  that	  native	  to	  the	  TG	  or	  examining	  the	  gD	  response	  of	  CD4+	  T	  cells	  in	  the	  TG	  at	  later	  time	  points	  post-­‐infection	  will	   likely	  indicate	  if	  these	  CD4+	  T	  cells	  have	  TCR-­‐specificity	  for	  this	  gD	  epitope.	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5.0	  CD4+	  T	  CELL	  INTERACTIONS	  IN	  THE	  LATENTLY	  INFECTED	  TG	  	  	  
5.1	  INTRODUCTION	  
	  It	   remains	  unclear	   if	  CD4+	  T	  cells	   found	   in	   the	   latently	   infected	  TG	  are	  specific	   for	  HSV-­‐1	  antigen	  and,	  if	  so,	  if	  they	  are	  exposed	  to	  antigen	  within	  this	  tissue.	  Studies	  conducted	  by	  the	  Verjans	   laboratory	   indicate	   that	   Satellite	  Glial	  Cells	   (SGCs)	  within	   the	  human	  TG	  bear	   an	  APC	  phenotype,	  showing	  expression	  of	  numerous	  APC	  markers	  including	  CD11c,	  CD80	  and	  86,	   and	   MHCII	   [87].	   vanVelzen	   and	   Verjans	   also	   reported	   that	   CD4+	   T	   cells	   in	   HSV-­‐1-­‐infected	  human	  TGs	  are	  found	  surrounding	  neurons	  in	  clusters,	  display	  antigen-­‐specificity	  for	  a	  broad	  range	  of	  HSV-­‐1	  proteins,	  and	  show	  evidence	  of	  recent	  activation	  [38]	  indicating	  that	  CD4+	  T	  cells	  are	  likely	  being	  activated	  in	  the	  local	  tissue	  and	  not	  in	  the	  periphery	  prior	  to	  migration	  to	  the	  TG.	  It	  has	  also	  been	  well	  demonstrated	  that	  DC	  populations	  are	  capable	  of	   eliciting	   robust	   antigen-­‐specific	   responses	   from	  both	   CD4	   and	  CD8+	   T	   cells	   present	   in	  peripheral	   tissues	   following	   viral	   infection,	   including	   HSV-­‐1	   [63,	   66-­‐68].	   Given	   these	  findings,	   it	   appears	   that	  both	  hematopoietic	  and	  non-­‐hematopoietic	   cell	  populations	  may	  be	  capable	  of	  serving	  as	  APCs	  to	  activate	  CD4+	  T	  cells	  within	  the	  TG.	  	  Data	   providing	   direct	   evidence	   of	   CD4+	   T	   cell	   activation	   in	   the	   TG	   has	   yet	   to	   be	  published	  and	  HSV-­‐1	  proteins	  are	  rarely	  detected	  in	  the	  TG	  during	  studies	  examining	  latent	  HSV-­‐1	   infection,	   calling	   into	   question	   the	   availability	   of	   antigen	   for	   APCs	   to	   acquire	   and	  present.	   However,	   HSV-­‐1	   lytic	   gene	   transcripts	   have	   been	   identified	   in	   the	   neurons	   of	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infected	   human	   TGs	   and	   neuronal	   cells	   positive	   for	   these	   transcripts	   have	   increased	  numbers	  of	  CD8+	  T	  cells	  surrounding	  them	  [36].	  We	  have	  shown	  that	  nearly	  all	  CD8+	  T	  cells	  in	  the	  TG	  during	  latent	  HSV-­‐1	  infection	  are	  antigen	  specific.	  And	  that	  non	  HSV-­‐specific	  CD8+	  T	   cells	   are	   lost	   from	   the	   latently	   infected	   TG	   over	   time.	   This	   implies	   that	   viral	   proteins	  persistently	  stimulate	  the	  T	  cells	  within	  the	  latently	  infected	  TG.	  Indeed,	  it	  is	  possible	  that	  HSV-­‐1	  proteins	  are	  produced	  but	  are	  produced	  at	  levels	  below	  detection	  and/or	  are	  taken	  up	  and	  processed	  too	  rapidly	  to	  accumulate	  to	  detectable	  levels.	  We	  postulate	  that	  CD4+	  T	  cells	  are	  activated	  in	  an	  HSV-­‐specific	  manner	  within	  the	  latently	  infected	  TG	  and	  we	  wish	  to	  identify	  the	  MHCII+	  APC	  population(s)	  that	  stimulates	  CD4+	  T	  cells	  in	  this	  tissue.	  Here,	  we	  describe	   the	   results	   of	   2	   experiments	   examining	   the	   interactions	   of	   CD4+	   T	   cells	   in	   the	  latently	  infected	  TG.	  	  
5.2	  MATERIALS	  AND	  METHODS	  
	  C57BL/6	   mice	   were	   bilaterally	   infected	   with	   1	   X	   105	   PFU	   HSV-­‐1-­‐KOS/cornea.	   B6.Cg-­‐Gt(ROSA)26Sortm14(CAG-­‐tdTomato)Hze/J	   (ROSA)	  mice	  were	   infected	  bilaterally	  with	  3X105	  PFU	  HSV-­‐1-­‐SV40-­‐Cre	  virus/	  cornea.	  TGs	  were	  harvested	  from	  mice	  at	  time	  points	  indicated	  and	  were	  imaged	  non-­‐fixed	  before	  a	  24-­‐hour	  room-­‐temperature	  fixation	  in	  4%	  PFA	  (Figure	  8)	  or	  were	  placed	  in	  4%	  PFA	  immediately	  without	  prior	  imaging	  (Figure	  7).	  TGs	  were	  treated	  with	  sodium	  borohydrate	  (NaBH4)	  to	  reduce	  autofluorescence	  and	  permeabilized	  in	  0.3%	  TritonX-­‐100	  in	  1X	  PBS	  containing	  2%	  BSA.	  Both	  incubations	  were	  carried	  out	  for	  30	  min.	  at	  room	  temp.	  ROSA	  TGs	  were	  then	  stained	  with	  anti-­‐NeuN-­‐AF488	  and	  anti-­‐CD4-­‐APC	  (Figure	  8)	   and	   B6	   TGs	   were	   stained	   with	   anti-­‐NeuN-­‐AF488,	   anti-­‐CD4-­‐PE,	   anti-­‐F4/80-­‐APC,	   and	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primary	  mouse	  anti-­‐glutamine	  synthetase	  (GS)	  antibody	  (Figure	  7).	  	  All	  stains	  prepared	  in	  blocking	  buffer	  (0.3%	  TritionX-­‐100	  and	  0.1%	  Tween-­‐20	  in	  1X	  PBS)	  and	  staining	  carried	  out	  overnight	  in	  the	  dark	  at	  4°C.	  TGs	  shown	  in	  figure	  7	  were	  also	  stained	  for	  2	  hours	  in	  the	  dark	  in	  a	  secondary	  goat	  anti-­‐mouse-­‐PacBlue	  antibody.	  TGs	  were	  whole	  mounted	  on	  glass	  slides	  with	  coverslips	  and	  images	  collected	  on	  an	  Olympus	  Fluoview	  1000X	  confocal	  microscope.	  Images	  captured	  with	  a	  20X.	  0.85NA	  (8,	  A	  &	  B)	  or	  40X,	  1.3NA	  (8,	  C	  &	  D)	  oil	  immersion	  objective.	  All	  image	  reconstructions	  created	  using	  Olympus	  Fluoview	  and	  Fiji	  software.	  Images	  were	  adjusted	  for	  display.	  	  
5.3	  RESULTS	  
	  In	   a	   preliminary	   experiment	   C57BL/6	  mice	  were	   bilaterally	   infected	  with	   1X105	   PFU	   of	  HSV-­‐1-­‐KOS	   virus/cornea.	   At	   30	   DPI	   TGs	  were	   harvested,	  whole	  mounted,	   and	   antibody-­‐labeled	   for	   CD4,	   NeuN,	   glutamine	   synthetase	   (GS),	   and	   F4/80	   and	  were	   then	   imaged	   by	  confocal	  microscopy.	  We	  observed	  CD4+	  T	  cell	  colocalization	  with	  F4/80+	  cells	  and	  in	  close	  apposition	   to	  GS+	   and	  NeuN+	  cells	   (Figure	   7),	   indicating	   that	   there	   are	  potentially	   direct	  interactions	   occurring	   between	   CD4+	   cells	   and	   macrophages,	   Satellite	   Glial	   Cells	   (SGCs),	  and/or	  neurons	  within	  the	  TG.	  	  To	   delineate	  whether	   or	   not	   CD4+	   T	   cells	   present	   in	   the	   latently	   infected	  TG	   interact	  specifically	   with	   HSV-­‐1-­‐infected	   neurons,	   we	   utilized	   the	   B6.Cg-­‐Gt(ROSA)26Sortm14(CAG-­‐
tdTomato)Hze/J	   strain	   of	   mice	   whose	   cells	   express	   the	   fluorescent	   TdTomato	   protein	   in	   the	  presence	  of	  Cre,	  a	  DNA	  recombinase	   [88].	  These	  mice	  were	   infected	  with	  an	  HSV-­‐1	  virus	  engineered	  to	  express	  Cre	  protein	  from	  an	  SV40	  promoter.	  	  Expression	  of	  Cre	  in	  neurons	  in	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the	  ROSA	  mouse	  results	  in	  expression	  of	  the	  fluorescent	  TdTomato	  protein	  within	  infected	  neurons	  and	  these	  cells	  will	  glow	  red	  in	  comparison	  to	  non-­‐infected	  neuronal	  cells.	  As	  such,	  we	  believe	  we	  can	  utilize	  this	  system	  to	  examine	  CD4+	  T	  cell	   interactions	  in	  the	  intact	  TG	  and	  determine	  if	  these	  cells	  are	  specifically	  interacting	  with	  HSV-­‐infected	  neurons.	  	  	  	  	  
	  
Figure	   7.	   CD4+	   T	   cells	   are	   in	   close	   apposition	   to	   F4/80+	   cells	   and	   neurons	   in	   latent	  HSV-­‐1	  
infection	  in	  WT	  B6	  mice.	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Figure	   8.	   CD4+	   T	   cells	   are	   present	   in	   high	   numbers	   and	   apposed	   to	   neurons	   during	   acute	  
HSV-­‐1	  infection	  in	  ROSA-­‐TdTomato	  mice.	  
	  B6.Cg-­‐Gt(ROSA)26Sortm14(CAG-­‐tdTomato)Hze/J	  mice	  were	  bilaterally	  infected	  with	  3	  X	  105	  PFU	  of	  HSV-­‐1-­‐SV40-­‐Cre	   virus.	   At	   10	   DPI,	   naïve	   (A)	   or	   latently	   infected	   (B)	   TGs	   were	   harvested	   and	   whole	  mounted.	  TdTomato	  expression	  was	  assessed	  by	  confocal	  microscopy	  (20x,	  Scale	  bar	  =	  100um)	  and	  clearly	  demonstrates	  a	   lack	  of	  expression	   in	   infected	  TGs	   in	  comparison	   to	  non-­‐infected	  samples.	  HSV-­‐1-­‐infected	  TGs	  were	   then	   fixed	  and	  stained	  (C,	  with	  a	  close-­‐up	   image	  shown	   in	  D)	  with	  anti-­‐NeuN-­‐488	  (green)	  and	  anti-­‐CD4-­‐APC	  (red)	  before	  imaging	  (40x,	  Scale	  bar	  =	  50um).	  CD4+	  T	  cells	  are	  shown	   surrounding	   neurons,	   indicating	   potential	   for	   TCR:peptide:MHCII	   interactions	   and	   CD4+	  T	  cell	  activation.	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Ten	  days	  following	  HSV-­‐1-­‐Cre	  infection,	  ROSA	  TGs	  were	  harvested	  and	  whole	  mounted	  live	   for	   confocal	   imaging.	   We	   noticed	   a	   high	   level	   of	   background	   fluorescence	   in	   both	  infected	   and	   non-­‐infected	   TG	   samples	   (Figure	   8,	   A	   &	   B).	   Given	   these	   high	   levels	   of	  background	   fluorescence,	   we	   were	   unable	   to	   clearly	   identify	   HSV-­‐infected	   versus	   non-­‐infected	   neuronal	   cells.	   We	   chose	   to	   fix	   and	   stain	   these	   TGs	   to	   determine	   CD4+	   T	   cell	  presence	  and	  localization	  within	  the	  TG.	  Whole	  TGs	  were	  stained	  with	  anti-­‐CD4	  and	  anti-­‐NeuN	   prior	   to	   being	   imaged	   by	   confocal	   microscopy.	   A	   large	   CD4+	   T	   cell	   infiltrate	   was	  present	  in	  the	  TGs	  of	  HSV-­‐1-­‐Cre	  infected	  ROSA	  mice	  at	  10DPI	  and	  a	  majority	  of	  these	  CD4+	  T	  cells	  were	  in	  close	  apposition	  to	  neurons	  (Figure	  8,	  C	  &	  D).	  	  	  
5.4	  DISCUSSION	  AND	  FUTURE	  DIRECTIONS	  
	  We	  were	  unable	  to	  identify	  infected	  neurons	  based	  on	  TdTomato	  expression	  in	  our	  ROSA	  mice	  infected	  with	  HSV-­‐1-­‐SV40-­‐Cre	  virus,	  even	  when	  using	  a	  dose	  of	  virus	  3	  times	  greater	  than	   that	   typically	   given	   of	   our	   laboratory	   HSV-­‐1-­‐KOS	   strain.	   This	   prevented	   us	   from	  assessing	  the	  specificity	  of	  CD4+	  T	  cell	  associations	  with	  infected	  cells	  versus	   interactions	  with	  non-­‐infected	  cells	  in	  the	  TG	  at	  10DPI	  (Figure	  8,	  A	  &	  B).	  However,	  additional	  HSV-­‐1-­‐Cre	   viruses,	   generously	   provided	   by	   Dr.	   Stacey	   Efstathiou	   (University	   of	   Cambridge,	  Cambridge,	   UK),	   will	   be	   examined	   in	   ROSA	   mice	   in	   future	   experiments.	   The	   HSV-­‐1-­‐Cre	  viruses	  provided	  by	  Dr.	  Efstathiou	  have	  been	  well	  established	  as	  effective	  tools	  with	  which	  to	  study	  HSV-­‐1-­‐infection	  in	  mouse	  models	  of	  neuronal	  infection	  [89-­‐91]	  and	  may	  allow	  us	  to	  more	  readily	  differentiate	  between	  infected	  and	  non-­‐infected	  neuronal	  cells	  within	  the	  TG.	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While	  we	  could	  not	  identify	  infected	  neurons	  in	  the	  TG	  at	  10	  DPI	  with	  certainty,	  we	  did	  observe	  a	  significant	  CD4+	  T	  cell	  infiltrate	  within	  the	  TG	  and	  a	  majority	  of	  these	  cells	  were	  closely	  apposed	  to	  neurons	  (Figure	  8,	  C	  &	  D),	  indicating	  potential	  direct	  interactions	  with	  these	   cells.	   The	   numbers	   of	   CD4+	   T	   cells	   in	   the	   TG	   during	   primary	   infection	  were	  much	  greater	  than	  that	  observed	  in	   latent	   infection,	  consistent	  with	  observations	  made	  of	  CD8+	  cells	  in	  our	  previous	  studies	  [43,	  92-­‐94].	  As	  CD4+	  T	  cells	  are	  in	  close	  apposition	  to	  neuronal	  cells	  within	  the	  TG	  during	  both	  acute	  and	  latent	  infection	  (Figures	  7	  &	  8),	  neurons	  or	  the	  satellite	   cells	   associated	   with	   them	   are	   of	   key	   interest	   to	   us	   in	   our	   studies	   of	   antigen	  presentation	   to	   CD4+	   T	   cells	   in	   the	   TG.	   The	   association	   of	   CD4+	   T	   cells	   with	   neurons	  following	  HSV-­‐1	   infection	   is	   in	  agreement	  with	  observations	  made	   in	  human	   tissues	   that	  indicate	  that	  HSV-­‐1-­‐specific	  CD4+	  T	  cells	  cluster	  around	  neurons,	  particularly	  those	  positive	  for	   HSV-­‐1	   transcripts	   [38],	   bolstering	   our	   hypothesis	   that	   CD4+	   T	   cells	   in	   the	   latently	  infected	   TG	   are	   an	   HSV-­‐specific	   population	   that	   is	   exposed	   to	   antigen	   in	   this	   tissue.	  However,	  additional	  studies	  are	  needed	  to	  examine	  the	  MHCII	  expression	  within	  neurons	  and	  SGCs	  in	  the	  TG.	  Additionally,	  ex	  vivo	  assessment	  of	  their	  ability	  to	  activate	  CD4+	  T	  cells	  isolated	  from	  the	  TGs	  of	  HSV-­‐1-­‐infected	  mice	  must	  be	  conducted	  to	  determine	  if	  these	  cell	  populations	  are	  in	  fact	  capable	  of	  activating	  CD4+	  T	  cells	  in	  the	  presence	  of	  HSV-­‐1.	  	  In	   addition	   to	   neurons,	   CD4+	  T	   cells	  were	   also	   in	   close	   apposition	   to	   cells	   expressing	  F4/80	   within	   the	   TG	   during	   latent	   HSV-­‐1	   infection	   (Figure	   7),	   which	   may	   be	   tissue-­‐resident	  DCs	  or	  macrophages	  that	  can	  act	  as	  APCs	  to	  CD4+	  T	  cells	  during	   latency.	  We	  did	  not	  assess	  F4/80+	  cell:CD4+	  T	  cell	   interactions	   in	  primary	   infection	  so	   it	   is	  unclear	   if	   this	  same	   pattern	   of	   localization	   exists	   early	   in	   HSV-­‐1	   infection.	   In	   future	   studies	   we	   will	  attempt	   to	   better	   define	   this	   F4/80+	   population	   by	   staining	   for	   additional	   markers	   of	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myeloid	  populations,	  such	  as	  Ly6C,	  CD11b,	  and	  CD11c	  [95].	  This	  will	  help	  us	  determine	  if	  these	   cells	   are	   a	   tissue-­‐resident	   DC	   population	   or	   another	   myeloid	   population	   such	   as	  macrophages.	  If	  we	  observe	  that	  the	  cells	  opposed	  to	  CD4+	  T	  cells	  in	  the	  TG	  are	  CD11b+	  and	  F4/80+,	  but	  CD11c	  and	  Ly6C	  negative,	  we	  can	  be	  more	  confident	  that	  these	  cells	  are	  tissue-­‐resident	  macrophages.	  Tissue-­‐resident	  DCs	  have	  been	  observed	  to	  stimulate	  CD4+	  T	  cells	  in	  the	  skin	  following	  HSV-­‐1	  infection	  [96]	  and	  this	  may	  also	  occur	  in	  the	  TG.	  If	  expression	  of	  Ly6C	  is	  observed,	  the	  cells	  are	  likely	  a	  macrophage	  population,	  which	  may	  also	  be	  capable	  of	  presenting	  antigen	  to	  CD4+	  T	  cells.	  We	  will	  also	  examine	  MHCII	  expression	  in	  these	  cells	  and	  assess	  the	  ability	  of	  this	  myeloid	  population	  to	  activate	  CD4+	  T	  cells	  isolated	  from	  HSV-­‐1-­‐infected	  TGs	  ex	  vivo.	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6.0	  THE	  ROLE	  OF	  IL-­‐10	  IN	  THE	  TG	  DURING	  LATENT	  HSV-­‐1	  INFECTION:	  SOURCES	  OF	  
IL-­‐10	  IN	  THE	  LATENTLY	  INFECTED	  TG	  AND	  THE	  EFFECT	  OF	  CD4	  DEPLETION	  ON	  CD8	  
FUNCTION	  AND	  VIRAL	  LATENCY	  	  	  
6.1	  INTRODUCTION	  
	  Recent	   studies	   in	   our	   laboratory	   have	   shown	   that	   nearly	   20%	   of	   CD4+	   T	   cells	   in	   the	   TG	  during	  latent	  HSV-­‐1	  infection	  are	  expressing	  the	  anti-­‐inflammatory	  cytokine	  IL-­‐10	  and	  that	  blockade	   of	   IL-­‐10	   receptor	   results	   in	   an	   increase	   in	   the	   functionality	   of	   subdominant	  epitope-­‐specific	  CD8+	  T	  cells	  and	  a	  reduced	  rate	  of	  HSV-­‐1	  reactivation	  [45].	  IL-­‐10	  is	  known	  to	   have	   suppressive	   functions	   in	   mediating	   the	   immune	   response	   to	   numerous	   insults,	  including	  viral	   infections.	  We	  hypothesize	  that	  CD4+	  T	  cells	  mediate	  CD8+	  T	  cell	   functions	  within	   the	   latently	   infected	   TG	   thus,	   in	   part,	   mediating	   HSV-­‐1	   latency	   and	   reactivation	  events.	  We	  postulate	  that	  IL-­‐10	  may	  be	  a	  critical	  chemical	  factor	  secreted	  by	  CD4+	  T	  cells	  to	  mediate	  CD8+	  T	  cell	  functions.	  However,	  we	  cannot	  discount	  the	  possibility	  that	  additional	  immune	  cell	  populations	  may	  also	  produce	  IL-­‐10	  to	  mediate	  HSV-­‐1	  latency	  in	  the	  TG.	  Here,	  we	  examine	  CD8+	  T	   cell	   function	   following	  CD4+	  T	   cell	  depletion	  during	   latency	  and	  also	  examine	  the	  TG	  for	  additional	  sources	  of	  IL-­‐10	  in	  hopes	  of	  gaining	  a	  better	  understanding	  of	  the	  role	  of	  IL-­‐10	  and	  CD4+	  T	  cells	  in	  latent	  HSV-­‐1	  infection.	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6.2	  MATERIALS	  AND	  METHODS	  
6.2.1	  In	  vivo	  CD4+	  T	  cell	  depletions	  	  
	  Latently	  infected	  C57BL/6	  (Figure	  9)	  or	  B6.129S6-­‐Il10tmlFlv/J	  (Figures	  10	  &	  11)	  mice	  were	  administered	  150μg	  in	  100μl	  of	  anti-­‐CD4	  antibody	  (BioXCell,	  West	  Lebanon,	  NH)	  or	  100μl	  1X	  PBS	  by	  i.p.	  injection	  at	  30,	  35,	  40,	  and	  45	  days	  post-­‐infection.	  TGs	  were	  harvested	  at	  46	  DPI	  and	  were	  processed	  into	  single	  cell	  suspensions	  before	  being	  stained	  for	  30	  minutes	  at	  room	   temperature	   with	   the	   following:	   anti-­‐CD4-­‐PacBlue,	   anti-­‐CD8-­‐APC-­‐Cy7,	   anti-­‐CD45-­‐PerCP,	   and	   gB	   tetramer.	   Samples	   shown	   in	   Figure	   11	   were	   also	   stained	   with	   anti-­‐PD-­‐1.	  Cells	  were	  washed	  in	  FACS	  buffer	  and	  fixed	  in	  100μl	  Cytofix/Cytoperm	  (BD)	  before	  being	  washed	  in	  1X	  Perm	  Wash	  (BD)	  and	  stained	  for	  intracellular	  GrzB.	  Fixation	  and	  intracellular	  staining	  steps	  were	  carried	  out	  in	  the	  dark	  at	  4°C	  for	  30	  minutes.	  Cells	  were	  then	  assessed	  by	  flow	  cytometry.	  	  
6.2.2	  Assessment	  of	  IL-­‐10	  production	  in	  the	  TG	  following	  HSV-­‐1	  infection	  
	  
	  TGs	   from	   B6.129S6-­‐Il10tmlFlv/J	   mice	   were	   harvested	   and	   processed	   into	   single	   cell	  suspensions	  at	  time	  points	  indicated.	  In	  Figure	  12,	  TGs	  from	  each	  mouse	  were	  pooled	  and	  divided	   in	   4	   (1/2	  TG/sample)	   before	   being	   stained	  with:	   anti-­‐	   CD45-­‐PerCP,	   CD4-­‐PE,	   and	  F4/80-­‐PE-­‐Cy7	   in	   FACS	   buffer.	   In	   Figure	   13,	   whole	   TGs	   were	   stained	   with:	   anti-­‐	   CD45-­‐BV510,	  CD4-­‐PacBlue,	  and	  F4/80-­‐PE-­‐Cy7	  in	  FACS	  buffer.	  All	  samples	  stained	  for	  30	  minutes	  at	   4°C	   in	   the	   dark.	   Following	   staining	   all	   samples	  were	   fixed	   in	   100μl	   Cytofix/Cytoperm	  (BD)	  at	  4°	  for	  20	  min.	  before	  being	  washed	  in	  FACS	  buffer	  and	  analyzed	  by	  flow	  cytometry.	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6.3	  RESULTS	  
	  To	  examine	  the	  functions	  of	  IL-­‐10	  in	  latent	  HSV-­‐1	  infection,	  we	  first	  examined	  CD8+	  T	  cell	  function	  upon	  CD4+	  T	   cell	   depletion	  during	   latent	  HSV-­‐1	   infection.	  We	  observe	   exclusive	  expression	  of	  IL-­‐10	  by	  CD4+	  T	  cells	  in	  latent	  TGs	  and	  that	  blockade	  of	  IL-­‐10R	  increased	  the	  number	  and	   function	  of	  non-­‐gB-­‐specific	  CD8+	  T	   cells	   [45].	  As	   such,	  we	  hypothesized	   that	  depletion	   of	   CD4+	   T	   cells	   from	   the	   TG	   during	   latent	   infection	   would	   result	   in	   the	   same	  increase	  in	  number	  and	  function	  of	  non-­‐gB-­‐specific	  CD8+	  T	  cells	  seen	  with	  IL-­‐10R	  blockade.	  In	   a	   pilot	   study,	   CD4+	  T	   cells	  were	   depleted	   from	   latently	   infected	  B6	  mice	   and	   epitope-­‐specific	  CD8+	  T	  cell	  function	  was	  assessed	  (Figure	  9).	  Intraperitoneal	  injection	  of	  150μg	  of	  anti-­‐CD4	   neutralizing	   antibody	   every	   five	   days	   over	   the	   course	   of	   20	   days	   resulted	   in	   a	  significant	   reduction	   in	   CD4	   numbers,	   both	   in	   the	   TG	   (Figure	   9,	   A-­‐C)	   and	   systemically	  (data	  not	  shown).	  However,	   the	  depletion	  was	   incomplete	  and	  a	  significant	  population	  of	  CD4+	  T	  cells	  still	  remained	  in	  the	  ganglia	  following	  depletion	  (Figure	  9,	  A-­‐C).	  Examination	  of	   the	   CD8+	   population	   following	   CD4+	   T	   cell	   depletion	   showed	   a	   negligible	   decrease	   in	  CD8+	  T	  cell	  numbers	  (Figure	  9D)	  and	  that	  the	  proportion	  and	  number	  of	  gB-­‐specific	  and	  non	   gB-­‐specific	   cells	   within	   the	   CD8+	   population	   were	   not	   altered	   (Figure	   9,	   E-­‐F).	  Additionally,	   expression	   of	   GrzB	   and	   PD-­‐L1	   remained	   unchanged	   in	   both	   populations	  
(Figure	  9,	  G-­‐J).	  It	  is	  to	  be	  noted	  that	  the	  overall	  numbers	  of	  both	  CD4+	  and	  CD8+	  T	  cells	  in	  infected	  and	  non-­‐depleted	  mice	  in	  this	  experiment	  were	  significantly	  lower	  than	  is	  typically	  seen	  in	  the	  C57BL/6	  model	  of	  HSV-­‐1	  infection	  in	  our	  laboratory.	  Our	  preliminary	  study	  showed	  no	  alterations	  to	  CD8+	  T	  cell	  upon	  CD4+	  T	  cell	  depletion.	  However,	  the	  depletion	  was	  incomplete	  (Figure	  9,	  A-­‐C)	  so	  we	  could	  not	  determine	  if	  these	  were	  valid	  observations	  of	   the	   function	  of	  CD8+	  T	  cells	   in	   the	  absence	  of	  a	  robust	  CD4+	  T	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cell	  population	  or	  if	  they	  were	  the	  result	  of	  an	  incomplete	  depletion	  of	  CD4+	  T	  cells.	  As	  such,	  we	   repeated	   the	   experiment	   using	   B6.129S6-­‐Il10tmlFlv/J	   mice.	   These	   mice	   express	   a	  bicistronic	  message	   from	   the	   IL-­‐10	   promoter	   that	   encodes	   the	   IL-­‐10	   cytokine	   as	  well	   as	  green	  fluorescent	  protein	  (GFP).	  Expression	  of	  GFP	  from	  the	  mRNA	  occurs	  via	  an	  internal	  ribosome	   entry	   site	   (IRES)	   that	   is	   3’	   to	   the	   IL-­‐10	   protein-­‐coding	   region	  while	   the	   IL-­‐10	  mRNA	  is	  translated	  following	  traditional	  5’	  cap-­‐binding	  by	  cellular	  ribosomes.	  	  Thus,	  these	  mice	  can	  be	  used	  to	  monitor	  IL-­‐10	  expression	  via	  GFP	  with	  minimal	  disruption	  to	  native	  IL-­‐10	  protein	  expression.	  Female	  mice	  were	  infected	  and	  depleted	  of	  CD4+	  cells	  as	  before,	  and	  CD8+	   T	   cell	   function	   in	   the	   TG	   was	   assessed	   (Figure	   10).	   Initial	   CD4+	   and	   CD8+	   T	   cell	  numbers	   were	   higher	   than	   in	   our	   pilot	   study	   (Figure	   10,	   A-­‐D)	   and	   we	   saw	   a	  proportionately	   greater	   reduction	   in	   CD4+	   T	   cells	   than	   was	   observed	   in	   our	   first	  experiment	  (Figure	  10B).	  While	  a	  smaller	  percentage	  of	  CD4+	  T	  cells	  was	  observed,	  there	  was	  still	  a	  greater	  number	  of	  CD4+	  T	  cells	  remaining	  in	  the	  TG	  following	  depletion	  in	  our	  second	   experiment	   than	   were	   remaining	   in	   our	   pilot	   depletion	   experiment	   (compare	  
Figure	  10C	  to	  Figure	  9C).	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Figure	  9.	  Partial	  depletion	  of	  CD4+	  T	  cells	  from	  the	  TG	  during	  HSV-­‐1	  latency	  in	  B6	  mice	  does	  
not	  result	  in	  an	  increase	  in	  epitope-­‐specific	  CD8+	  T	  cell	  numbers	  or	  functionality.	  
	  B6.129S6-­‐Il10tmvFlv/J	  mice	  were	  bilaterally	   infected	  with	  1X105	  PFU	  HSV-­‐1-­‐KOS.	  At	  30,	  35,	  40,	  and	  45DPI,	  150μg	  anti-­‐CD4	  antibody	  or	  100μl	  PBS	  was	  administered	  by	   intraperitoneal	   injection.	  TGs	  were	  harvested	  at	  46DPI	  and	  processed	  into	  single-­‐cell	  suspensions	  before	  being	  stained	  with	  anti-­‐	  CD45,	  CD8,	  CD4,	  gB,	  PD-­‐1,	  and	  GrzB	  antibodies	  and	  CD8	  function	  assessed	  by	  flow	  cytometry.	  (A)	  shows	   representative	   flow	   plots	   of	   CD4+	   and	   CD8+	   T	   cells	   isolated	   from	   B6	   TGs	   that	   were	   not	  depleted	  (left)	  or	  were	  depleted	  (right)	  of	  CD4+	  T	  cells.	  (B)	  shows	  a	  graphical	  representation	  of	  the	  data	  represented	  in	  (A).	  The	  number	  of	  CD4+	  and	  CD8+	  T	  cells	  found	  in	  the	  TGs	  of	  B6	  mice	  that	  have	  or	  have	  not	  been	  depleted	  of	  CD4+	  cells	  are	  shown	  in	  (C)	  and	  (D).	  The	  proportion	  (E)	  and	  number	  (F)	   of	   gB-­‐specific	   and	   non	   gB-­‐specific	   cells	   within	   the	   CD8+	   T	   population	   with	   (open	   circles)	   or	  without	  (filled	  circles)	  CD4+	  T	  cell	  depletion	  are	  indicated.	  The	  proportion	  and	  numbers	  of	  gB+	  (G-­‐H)	  and	  gB-­‐	  (I-­‐J)	  CD8+	  T	  cells	  expressing	  GrzB	  and	  PD-­‐1	  with	  (open	  circles)	  or	  without	  (filled	  circles)	  CD4	  depletion	  are	  shown	  in	  (G-­‐J).	  All	  flow	  cytometry	  plots	  shown	  were	  previously	  gated	  CD45.	  All	  bars	  represent	  the	  mean	  ±	  SEM	  of	  cell	  type	  indicated.	  Data	  is	  representative	  of	  a	  single	  experiment	  (N=5/treatment	   group).	   Statistical	   analyses	   conducted	   using	   a	   student’s	   t-­‐test	   with	   Welch’s	  correction	  in	  GraphPad	  Prism	  6.	  **p=0.0069,	  *p=0.0376.	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Figure	   10.	   Partial	   depletion	   of	   CD4+	   T	   cells	   from	   the	   TGs	   of	   IL-­‐10-­‐GFP	  mice	   during	   HSV-­‐1	  
latency	   results	   in	   a	   significant	   increase	   in	   non-­‐gB-­‐specific	   CD8+	   T	   cell	   numbers	   and	   an	  
increase	  in	  GrzB	  expression.	  
	  B6.129S6-­‐Il10tmvFlv/J	  mice	  were	  bilaterally	  infected	  with	  1X105	  PFU	  HSV-­‐1-­‐KOS	  virus.	  At	  30,	  35,	  40,	  and	  45DPI,	  150μg	  anti-­‐CD4	  antibody	  or	  100μl	  PBS	  was	  administered	  by	   intraperitoneal	   injection.	  TGs	  were	  harvested	  at	  46DPI	  and	  processed	  into	  single-­‐cell	  suspensions	  before	  being	  stained	  with	  anti-­‐	  CD45,	  CD8,	  CD4,	  gB,	   and	  GrzB	  antibodies	  and	  CD8	   function	  assessed	  by	   flow	  cytometry.	   (A)	  shows	   representative	   flow	   plots	   of	   CD4+	   and	   CD8+	   T	   cells	   isolated	   from	   B6	   TGs	   that	   were	   not	  depleted	  (left)	  or	  were	  depleted	  (right)	  of	  CD4+	  T	  cells.	  (B)	  shows	  a	  graphical	  representation	  of	  the	  data	  represented	  in	  (A).	  The	  number	  of	  CD4+	  and	  CD8+	  T	  cells	  found	  in	  the	  TGs	  of	  B6	  mice	  that	  have	  or	  have	  not	  been	  depleted	  of	  CD4+	  cells	  are	  shown	  in	  (C)	  and	  (D).	  The	  proportion	  (E)	  and	  number	  (F)	   of	   gB-­‐specific	   and	   non	   gB-­‐specific	   cells	   within	   the	   CD8+	   T	   population	   with	   (open	   circles)	   or	  without	  (filled	  circles)	  CD4+	  T	  cell	  depletion	  are	  indicated.	  The	  proportion	  and	  numbers	  of	  gB+	  (G-­‐H)	   and	   gB-­‐	   (I-­‐J)	   CD8+	   T	   cells	   expressing	   GrzB	  with	   (open	   circles)	   or	  without	   (filled	   circles)	   CD4	  depletion	   is	  shown	   in	   (G-­‐J).	  All	   flow	  cytometry	  plots	  shown	  were	  previously	  gated	  CD45.	  All	  bars	  represent	   the	   mean	   ±	   SEM	   of	   cell	   type	   indicated.	   Data	   is	   representative	   of	   a	   single	   experiment	  (N=2/treatment	   group).	   Statistical	   analyses	   created	   using	  GraphPad	   Prism	  6.	   Statistic	   in	   (B)	  was	  generated	  by	  conducting	  a	  student’s	  t-­‐test	  with	  Welch’s	  correction,	  **p=0.0058.	  Statistic	  in	  (F)	  was	  generated	  by	  conducting	  a	  Two-­‐way	  ANOVA	  with	  multiple	  comparisons,	  *p<0.05.	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In	  our	  second	  CD4+	  T	  cell	  depletion	  experiment	  we	  observed	  a	  slight	  increase	  in	  overall	  CD8+	   T	   cell	   numbers	   and	   a	   significant	   increase	   in	   the	   number	   of	   subdominant	   epitope-­‐specific	  CD8+	  T	  cells	   in	   the	  TG	   that	  had	  not	  been	  seen	   in	  our	  pilot	  experiment	  (compare	  
Figure	   10,	   D-­‐F	   to	   Figure	   9,	   D-­‐F).	   Additionally,	  we	   observed	   a	   trend	   of	   increased	   GrzB	  expression	   in	   both	   gB-­‐specific	   and	   non	   gB-­‐specific	   CD8+	   T	   cells	   following	   CD4	   depletion	  that	  was	  also	  not	  observed	  in	  our	  pilot	  study	  (compare	  Figure	  10,	  G-­‐J	   to	  Figure	  9,	  G-­‐J).	  	  We	  also	  attempted	  to	  examine	  HSV-­‐1	  reactivation	  in	  TGs	  depleted	  or	  not	  depleted	  of	  CD4+	  T	  cells	  ex	  vivo,	  but	  results	  from	  this	  study	  were	  inconclusive	  (data	  not	  shown).	  As	  such,	  it	  remains	  unclear	  if	  this	  increase	  in	  non-­‐gB	  CD8+	  T	  cells	  and	  GrzB	  expression	  translates	  to	  a	  reduced	  frequency	  of	  HSV-­‐1	  reactivation.	  To	  determine	  if	  remaining	  CD4+	  T	  cells	  had	  an	  altered	  IL-­‐10	  expression	  phenotype,	  we	  examined	  the	  IL-­‐10-­‐GFP	  MFI	  within	  these	  cells	  and	  compared	  it	  to	  that	  in	  CD4+	  T	  cells	  from	  non-­‐depleted	   mice.	   We	   found	   that	   there	   was	   roughly	   the	   same	   number	   of	   CD4+	   T	   cells	  expressing	   IL-­‐10	   in	   TGs	   depleted	   of	   CD4+	   cells	   as	   there	   were	   in	   TGs	   that	   had	   not	   been	  depleted	   of	   CD4+	   cells	   (Figure	   11B).	   All	   CD4+	   T	   cells	   remaining	   in	   the	   TGs	   following	  depletion	  were	  IL-­‐10+,	  whereas	  only	  10-­‐15%	  of	  the	  CD4+	  T	  cells	  harvested	  from	  the	  TGs	  of	  mice	  not	  depleted	  of	  CD4+	  T	  cells	  were	  IL-­‐10+.	  (Figure	  11,	  A	  &	  C).	  However,	  the	  IL-­‐10-­‐GFP	  mean	  fluorescence	  intensity	  (MFI)	  was	  greatly	  reduced	  in	  the	  IL-­‐10+	  CD4+	  T	  cell	  population	  in	  the	  TGs	  of	  CD4-­‐depleted	  mice	  in	  comparison	  to	  IL-­‐10+	  CD4+	  T	  cells	  in	  non-­‐depleted	  mice	  
(Figure	   11D).	   This	   reduction	   in	  MFI	   was	   not	   statistically	   significant,	   but	   the	   pattern	   of	  reduced	  IL-­‐10	  levels	  within	  the	  CD4+	  cells	  was	  apparent.	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Figure	  11.	  CD4+	  T	  cells	  remaining	  in	  the	  TG	  following	  in	  vivo	  CD4+	  T	  cell	  depletion	  are	  IL-­‐10+,	  
but	  express	  less	  IL-­‐10/cell	  than	  CD4+	  T	  cells	  in	  TGs	  from	  non-­‐depleted	  mice.	  	  
	  B6.129S6-­‐Il10tmvFlv/J	  mice	  were	  bilaterally	  infected	  with	  1X105	  PFU	  HSV-­‐1-­‐KOS	  virus.	  At	  30,	  35,	  40,	  and	  45DPI,	  150μg	  anti-­‐CD4	  antibody	  or	  100μl	  PBS	  was	  administered	  by	   intraperitoneal	   injection.	  TGs	  were	  harvested	  at	  46DPI	  and	  processed	  into	  single-­‐cell	  suspensions	  before	  being	  stained	  with	  anti-­‐CD45	   and	   anti-­‐CD4	   and	   IL-­‐10-­‐GFP	   expression	   assessed	   by	   flow	   cytometry.	   (A)	   shows	  representative	  flow	  plots	  of	  IL-­‐10	  expression	  in	  CD4+	  T	  cells	  isolated	  from	  B6.129S6-­‐Il10tmvFlv/J	  TGs	  that	  were	  not	  depleted	  (left)	  or	  were	  depleted	  (right)	  of	  CD4+	  T	  cells.	  The	  number	  of	  CD4+	  T	  cells	  expressing	   IL-­‐10	   in	   the	  TGs	   of	   B6.129S6-­‐Il10tmvFlv/J	  mice	   that	   have	   or	   have	   not	   been	   depleted	   of	  CD4+	  cells	  is	  shown	  in	  (B).	  (C)	  shows	  a	  graphical	  representation	  of	  the	  data	  represented	  in	  (A).	  (D)	  is	  a	  representative	  graph	  of	  the	  IL-­‐10-­‐GFP	  MFI	  in	  CD4+	  T	  cells	  isolated	  from	  non-­‐depleted	  or	  CD4+	  T	  cell	  depleted	  IL-­‐10-­‐GFP	  reporter	  mice.	  All	  flow	  cytometry	  plots	  shown	  were	  previously	  gated	  CD45.	  All	   bars	   represent	   the	   mean	   ±	   SEM	   of	   cell	   type	   indicated.	   Data	   is	   representative	   of	   a	   single	  experiment	   (N=2/treatment	  group).	  Statistical	  analyses	  created	  using	  GraphPad	  Prism	  6.	  Statistic	  in	  (C)	  generated	  by	  conducting	  a	  student’s	  t-­‐test	  with	  Welch’s	  correction,	  *p=0.0103.	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Figure	  12.	  A	  large	  proportion	  of	  F4/80+	  cells	  present	  in	  the	  TG	  during	  primary	  lytic	  infection	  
express	  IL-­‐10.	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Although	   depletion	   of	   CD4+	   T	   cells	   does	   have	   a	   robust	   effect	   on	   non-­‐gB	   CD8+	   T	   cell	  numbers	   and	   also	   results	   in	   a	   pattern	   of	   increased	   GrzB	   expression	   in	   CD8+	   T	   cells,	   we	  cannot	   eliminate	   the	   possibility	   that	   other	   cell	   populations	   in	   the	   latently	   infected	   TG	  express	  IL-­‐10	  to	  modulate	  CD8+	  T	  cell	  function.	  An	  F4/80+	  population	  is	  present	  in	  the	  TGs	  of	  B6.129S6-­‐Il10tmlFlv/J	  mice	  at	  9DPI	  that	  is	  greater	  in	  number	  and	  proportional	  expression	  of	  IL-­‐10	  than	  CD4+	  T	  cells	  	  (Figure	  12).	  Given	  that	  F4/80+	  cells	  are	  expressing	  IL-­‐10	  in	  high	  numbers	  in	  the	  TG	  during	  acute	  infection,	  it	  is	  possible	  that	  an	  F4/80+	  IL-­‐10+	  population	  is	  present	  in	  the	  TG	  following	  the	  establishment	  of	  latent	  HSV-­‐1.	  	  	  
6.4	  DISCUSSION	  AND	  FUTURE	  DIRECTIONS	  
	  Since	  we	  had	  observed	  20%	  of	  CD4+	  T	  cells	  expressing	  IL-­‐10	  and	  blocking	  IL-­‐10R	  resulted	  in	  an	  increase	  in	  the	  number	  and	  functionality	  of	  subdominant	  epitope-­‐specific	  CD8+	  T	  cells	  [45],	  we	   anticipated	   a	   similar	   result	   upon	  depletion	  of	   CD4+	  T	   cells.	  However,	   our	   initial	  study	  examining	  the	  effects	  of	  CD4	  depletion	  on	  CD8+	  T	  cell	  functions	  indicated	  that	  there	  was	  no	  requirement	   for	  CD4+	  T	  cells	   in	   the	  regulation	  of	  CD8+	  T	  cell	   function	  (Figure	   9).	  This	   indicated	  one	  of	   two	  things:	  1)	  CD4+	  T	  cells	  are	  not	   the	  primary	  contributors	  of	   this	  cytokine	   or	   2)	   an	   additional	   immune	   cell	   population	   is	   capable	   of	   up-­‐regulating	   IL-­‐10	  expression	   in	   the	  absence	  of	  CD4+	  T	  cells.	  However,	  given	   the	   low	  T	  cell	  numbers	   in	   this	  experiment,	  it	  is	  also	  possible	  that	  this	  is	  not	  representative	  of	  a	  typical	  immune	  response	  to	  HSV-­‐1	   and	   CD8+	   T	   cell	   response	   to	   a	   lack	   of	   CD4	   presence.	   As	   such,	  we	   repeated	   the	  depletion	   experiment	   (Figures	   10	   and	   11)	   and	   examined	   IL-­‐10	   expression	   in	   cell	  populations	  other	  than	  CD4+	  T	  cells	  within	  the	  TG	  following	  HSV-­‐1	  infection	  (Figure	  12).	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When	  we	   repeated	   the	   CD4	   depletion	   experiment,	   the	   TG-­‐infiltrating	   T	   cell	   numbers	  were	  similar	  to	  those	  typically	  observed	  in	  our	  studies.	  	  The	  effect	  of	  CD4+	  T	  cell	  depletion	  on	  subdominant	  epitope-­‐specific	  CD8+	  T	  cells	   in	   this	  experiment	  was	  similar	   to	   the	  effect	  we	  had	  previously	   seen	  upon	   IL-­‐10R	  blockade	   (Figure	   10)	   [45],	   causing	  us	   to	   speculate	  that	   CD4+	   T	   cells	   may,	   in	   fact,	   be	   the	   key	   producers	   of	   the	   IL-­‐10	   that	   downregulates	  subdominant	  epitope-­‐specific	  CD8+	  T	  cell	  function	  in	  the	  TG	  during	  latent	  HSV-­‐1	  infection.	  CD4+	   T	   cell-­‐secreted	   IL-­‐10	   is	   known	   to	   dampen	   pro-­‐inflammatory	   immune	   responses	  during	  numerous	  persistent	  pathogenic	  infections	  including	  HCMV,	  LCMV,	  plasmodium,	  and	  
toxoplasma	   gondii	   [97-­‐101].	   Therefore,	   it	   is	   feasible	   that	   this	   also	   occurs	   during	   HSV-­‐1	  latency	  in	  the	  TG.	  The	  CD4+	  T	  cells	  that	  were	  remaining	  in	  TGs	  following	  depletion	  showed	  reduced	   IL-­‐10	  expression	  (Figure	   11),	   indicating	  a	  potential	   reduction	   in	   their	   ability	   to	  moderate	  CD8+	  T	  cell	  activity	  through	  expression	  of	  this	  cytokine.	  This	  would	  also	  help	  to	  explain	  the	  increase	  in	  CD8	  number	  and	  function	  even	  though	  CD4+	  T	  cells	  positive	  for	  IL-­‐10	  remain	  in	  the	  TG	  following	  depletion.	  	  Further	   studies	   are	   needed	   to	   assess	   the	   degree	   to	  which	   CD4+	   T	   cell-­‐secreted	   IL-­‐10	  regulates	   HSV-­‐1	   latency	   and	   reactivation.	   These	   will	   likely	   include	   examining	   the	  reactivation	   frequencies	   of	  TGs	  depleted	  of	  CD4+	  T	   cells	   concurrent	  with	   assessing	   IL-­‐10	  transcript	  or	  protein	  levels	  in	  these	  cultures.	  If	  these	  studies	  indicate	  a	  significant	  effect	  of	  CD4+	  T	  cell-­‐secreted	  IL-­‐10	  on	  HSV-­‐1	  reactivation,	  we	  will	  then	  examine	  means	  by	  which	  to	  reduce	  CD4+	  T	  cell	  numbers	  or	  IL-­‐10	  expression	  within	  the	  latently	  infected	  TG.	  Levels	  of	  IL-­‐10	  production	  in	  additional	   immune	  cell	  populations	  within	  the	   latently	   infected	  TG	  in	  the	  absence	  of	  CD4+	  T	  cells	  must	  also	  be	  determined	  to	  confirm	  that	  there	  is	  not	  additional	  IL-­‐10	  production	  in	  the	  TG.	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When	  we	  examined	  IL-­‐10	  expression	  in	  the	  TGs	  of	  IL-­‐10-­‐GFP	  reporter	  mice	  at	  9	  DPI,	  we	  did	  observe	  a	  large	  F4/80+	  cell	  population	  in	  the	  TG	  that	  was	  greater	  in	  size	  than	  the	  CD4+	  T	   cell	   population	   (Figure	   12).	  We	  had	   not	   observed	   this	   population	   in	   our	   initial	   study	  examining	   the	   sources	   of	   IL-­‐10	   in	   the	   TG	   during	   latency	   [45],	   but	   it	   is	   possible	   that	   this	  F4/80+	   IL-­‐10+	   cell	   population	   is	   an	   infiltrating	  or	   tissue-­‐resident	  macrophage	  population	  and	  is	  also	  present	  in	  latent	  HSV-­‐1	  infection.	  Macrophage	  populations	  are	  known	  to	  traffic	  to	  peripheral	  tissues	  and	  sites	  of	  immune	  activation	  to	  mediate	  primary	  immune	  responses	  in	   these	   areas.	   They	   are	   also	   known	   for	   their	   secretion	   of	   IL-­‐10	   to	   dampen	   the	  inflammatory	  response	  during	  chronic	  models	  of	  infection	  and	  cancer	  [102,	  103].	  Thus,	  this	  F4/80+	  cell	  population,	  if	  present	  in	  the	  TG	  during	  latent	  HSV-­‐1	  infection,	  may	  serve	  as	  an	  additional	   source	   of	   IL-­‐10	   that	   regulates	   CD8+	   T	   cell	   function	   thereby	   mediating	   HSV-­‐1	  latency	  and	  reactivation.	  	  We	  attempted	  to	  examine	  IL-­‐10	  expression	  in	  additional	  cell	  types,	  including	  in	  F4/80+	  cells,	   during	   latent	   HSV-­‐1	   infection	   in	   our	   IL-­‐10-­‐GFP	   reporter	   mice.	   However,	   this	  experiment	  yielded	  inconclusive	  data	  and	  must	  be	  repeated.	  If	  F4/80+	  cells	  are	  present	  and	  express	  IL-­‐1,	  in	  the	  TG	  during	  latent	  HSV-­‐1	  infection,	  we	  will	  further	  define	  this	  population	  by	  assessing	  surface	  marker	  expression	  of	  Ly6C,	  Ly6G,	  CD11b,	  and	  CD11c.	  These	  markers	  are	  known	  to	  be	  variably	  expressed	  on	  F4/80+	  macrophages,	  neutrophils,	  and	  DCs	  and	  can	  be	   used	   to	   differentiate	   the	   populations	   by	   flow	   cytometry	   and	   fluorescent	   imaging	   [95,	  104-­‐106].	  We	  will	   then	   attempt	   to	   assess	   the	   effects	   this	   population	   has	   on	   CD8+	   T	   cell	  function	   and	   HSV-­‐1	   latency	   as	   we	   have	   done	   here	   or	   propose	   to	   do	   with	   CD4+	   T	   cells.	  Finally,	  we	  will	  assess	  the	  effects	  of	  concurrent	  depletion	  of	  CD4+	  and	  F4/80+	  cells	  on	  CD8+	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T	   cell	   function	   and	   HSV-­‐1	   reactivation	   to	   determine	   if	   the	   effect	   of	   dual	   depletion	   is	  equivalent	  to	  that	  of	  CD4+	  T	  or	  F4/80+	  cell	  depletion	  alone.	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7.0	  SUMMARY	  AND	  CONCLUSION	  	  	  	  We	  set	  out	  to	  define	  the	  answers	  to	  three	  specific	  questions,	  as	  outlined	  in	  Chapter	  2.	  In	  our	  first	   aim	  we	  wished	   to	   define	   the	  HSV-­‐1-­‐specific	   CD4+	  T	   cell	   repertoire	   in	   the	  TGs	   of	   B6	  mice	  following	  HSV-­‐1	  infection.	  Here	  we	  have	  shown	  that	  a	  portion	  of	  CD4+	  T	  cells	  in	  the	  TG	  during	   latent	  HSV-­‐1	   infection	  specifically	  recognize	  HSV-­‐1	   in	  the	  presence	  of	  professional	  APCs	  ex	  vivo	  and	  respond	  by	  secreting	   IFN-­‐γ	  and	  IL-­‐10.	  We	  have	  also	  shown	  that	  a	  small	  but	   significant	   percentage	   of	   CD4+	   T	   cells	   present	   in	   the	   spleens	   of	   HSV-­‐1-­‐infected	  mice	  specifically	  recognize	  HSV-­‐1-­‐gD	  peptide	  and	  secrete	  IFN-­‐γ	  in	  response.	  However,	  we	  have	  yet	  to	  define	  the	   full	  spectrum	  of	  HSV-­‐1	  epitopes	  that	  CD4+	  T	  cells	  present	   in	  the	  spleens	  and	  TGs	  of	  infected	  mice	  recognize	  and	  will	  continue	  our	  studies	  to	  define	  the	  full	  HSV-­‐1-­‐specific	  CD4+	  T	  cell	  repertoire.	  This	  information	  will	  aid	  future	  investigators	  in	  examining	  the	  mechanisms	  of	   immune	   control	   of	   latent	  HSV-­‐1	   infection	   and	  may	  also	   shed	   light	   on	  HSV-­‐specific	  CD4+	  T	  cell	  populations	  that	  can	  be	  targeted	  for	  manipulation	  to	  mediate	  HSV-­‐1	  latency	  in	  the	  TG.	  In	   Aim	   2,	  we	   set	   out	   to	   define	   the	   interactions	   of	   CD4+	   T	   cells	  with	   other	   cell	   types,	  specifically	   with	   MHCII+	   cell	   populations,	   in	   the	   latently	   infeced	   TG	   and	   wished	   to	  determine	  if	  CD4+	  T	  cells	  isolated	  from	  TGs	  harboring	  latent	  HSV-­‐1	  infection	  are	  stimulated	  by	  these	  cells	  in	  the	  presence	  of	  HSV-­‐1	  antigen	  ex	  vivo.	  	  We	  found	  that	  CD4+	  T	  cells	  in	  the	  TG	  are	  apposed	  to	  F4/80+	  cells	  as	  well	  as	  neurons	  and	  possibly	  satellite	  glial	  cells	  associated	  with	  neurons.	  We	  have	  yet	  to	  assess	  MHCII	  expression	  within	  the	  TG	  during	  latent	  HSV-­‐1	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infection	  and	  thus,	  cannot	  say	  if	  these	  cell	  types	  have	  the	  potential	  to	  serve	  as	  APCs	  to	  CD4+	  T	  cells	   in	  this	  tissue.	  We	  will	  assess	  MHCII	  expression	  and	  will	  examine	  the	  ability	  of	  any	  MHCII+	   populations	   present	   in	   the	   TG	   to	   activate	   CD4+	   T	   cells	   ex	  vivo	   in	   the	   presence	   of	  HSV-­‐1	  antigen.	  Identification	  of	  a	  TG-­‐resident	  APC	  population	  capable	  of	  stimulating	  CD4+	  T	   cells	   may	   allow	   for	   the	   assessment	   of	   CD4+	   T	   cell	   activation,	   function,	   and	   exhaution	  levels	  within	  the	  TG.	  These	  studies	  will	  better	  define	  the	  functions	  of	  CD4+	  T	  cell	  population	  within	   the	   TG	   and	   may	   also	   yield	   insight	   into	   means	   by	   which	   CD4+	   T	   cells	   and	   APC	  populations	   within	   the	   HSV-­‐1-­‐infected	   TG	   can	   be	   activated	   or	   inactivated	   to	   modulate	  immune	  activity,	  particularly	  that	  of	  CD8+	  T	  cells,	  	  to	  prevent	  HSV-­‐1	  reactivation.	  In	  our	   final	   aim,	  we	  wanted	   to	   follow	  up	  on	   two	  earlier	  observations:	  1)	   that	  CD4+	  T	  cells	  present	  in	  the	  TG	  produce	  IL-­‐10	  and	  appear	  to	  be	  the	  sole	  population	  to	  do	  so	  and	  2)	  that	   blocking	   IL-­‐10	   signaling	   bolsters	   subdominant	   epitope-­‐specific	   CD8+	  T	   cell	   numbers	  and	  functionality	  and	  reduces	  HSV-­‐1	  reactivation	  frequency	  [45].	  In	  the	  current	  study,	  CD4+	  T	   cell	   depletion	   results	   in	   an	   increase	   in	   non	   gB-­‐specific	   CD8+	   T	   cell	   numbers	   and	   an	  increase	  in	  GrzB	  expression	  in	  both	  gB-­‐specific	  and	  non	  gB-­‐specific	  CD8+	  T	  cell	  populations,	  an	  expected	  result	  that	  is	  similar	  to	  that	  seen	  with	  IL-­‐10R	  blockade	  [45].	  This	  indicates	  that	  CD4+	   T	   cells	   are	   the	   dominant	   IL-­‐10	   producer	   in	   the	   TG	   and	   that	   they	   reduce	   non	   gB-­‐specific	   CD8+	   T	   cell	   functionality	   through	   IL-­‐10	   signaling.	   Reduced	   non-­‐gB	   CD8+	   T	   cell	  functionality	  results	  in	  an	  increased	  rate	  of	  HSV-­‐1	  reactivation	  and	  viral	  particle	  production	  [45].	   Additional	   studies	   to	   confirm	   these	   findings	   and	   further	   define	   the	   molecular	  mechanisms	  controlling	  both	  CD4+	  expression	  of	  and	  CD8+	  T	  cell	   responses	   to	   IL-­‐10	  may	  identify	  mechanisms	  that	  can	  be	  manipulated	  to	  bolster	  protective	  responses	  and	  prevent	  HSV-­‐1	   reactivation	   while	   minimizing	   immune-­‐mediated	   pathology.	   F4/80+	   cells	   also	  
	   52	  
produce	  IL-­‐10	  in	  the	  TG	  during	  acute	  infection,	  but	  it	  remains	  unclear	  if	  these	  cells	  express	  IL-­‐10	   in	   the	   TG	   upon	   the	   establishment	   of	   latent	   infection	   and	   this	   will	   be	   examined	   in	  future	  studies	  as	  was	  conducted	  with	  CD4+	  T	  cells.	  Collectively,	   these	  studies	  have	  and	  will	   continue	  to	  provide	  new	  insights	   into	  CD4+	  T	  cell	  activity	  in	  latent	  HSV-­‐1	  infection	  and	  may	  result	  in	  the	  generation	  of	  new	  tools	  such	  as	  HSV-­‐1:MHCII	  tetramers	  by	  which	  to	  examine	  CD4+	  T	  cells	  in	  HSV-­‐1	  infection.	  Furthermore,	  the	   information	   gained	   from	   these	   studies	   may	   aid	   in	   the	   development	   of	   therapeutic	  vaccines	  that	  modulate	  CD4+	  as	  well	  as	  CD8+	  T	  cell	   function	  in	  the	  TG	  to	  promote	  latency	  and	  prevent	  HSV-­‐1	  reactivation	  events	  and	  the	  pathologies	  associated	  with	  them.	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